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Abstract 
 The dramatic increase in obesity and its comorbidities in recent years highlight 
the critical importance of understanding the factors contributing to dysregulated energy 
balance.  While a relatively small percentage of genetic loci have been correlated with 
bodyweight, the genetic variations that have been characterized with obesity highlight 
hypothalamic circuits in the central nervous system (CNS) as an essential regulator of 
energy homeostasis.  The paraventricular nucleus of the hypothalamus (PVH) is a 
necessary node in satiety regulation, since alterations in PVH development or function 
in mice and humans result in hyperphagic obesity.  Yet, as a heterogenous nucleus, 
little is known about the specific cell-types used by the PVH to coordinate feeding 
suppression and/or energy expenditure.  Therefore, we first identified the circuitry of 
genetically-defined PVH subpopulations in order to hypothesize their functional 
relevance based on projection targets.  We combined this methodology with 
chemogenetic activation and neuronal ablation techniques to determine the function of 
separate PVH neuronal subpopulations in distinct energy balance parameters.  Finally, 
we attempted to characterize the neural circuit map of afferent inputs to specific PVH 
cell populations based on their projection targets with the hypothesis that disparate PVH 
physiologic outputs may be regulated by non-overlapping neural populations.    
 First, we identify a genetic PVH population expressing neuronal nitric oxide 
synthase 1 (Nos1) that is capable of feeding suppression, presumably through 
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projections to hindbrain regions known to be involved in feeding control.  Moreover, 
while PVH oxytocin (OXT) neurons, a subset of the Nos1PVH field, do not control feeding 
behavior, they are capable of increasing energy expenditure, likely through connections 
to the spinal cord.  We then characterize a non-Nos1, non-OXT PVH population 
expressing insulin receptor substrate 4 (IRS4) that is necessary for normal feeding.  
IRS4PVH neurons also regulate energy expenditure, highlighting the significance of 
multiple, mutually exclusive, PVH populations in both feeding and energy expenditure 
control.  Lastly, we highlight the dense interconnectivity of PVH subpopulations, with 
numerous PVH subtypes directly upstream of centrally-projecting PVH populations.  
Altogether, our results suggest the relevance of a complex intra-PVH network engaging 
distinct PVH subpopulations in order to ultimately coordinate feeding and energy 
expenditure regulation. 
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Chapter I 
 
Introduction: Hypothalamic circuits coordinating energy balance regulation 
 
As the prevalence of obesity and its complications continue to rise worldwide, so 
too do the associated financial and medical consequences.  Obesity is not merely a 
cosmetic issue, as it is associated with an increased incidence of type II diabetes, 
cardiovascular disease, cancer, sleep apnea, and a variety of mental health conditions, 
including depression (1-3).  In addition to contributing to other economic and societal 
burdens, obesity-related illness underlies 10% of current annual health care 
expenditures in the United States (4).  It is therefore crucial that we understand the 
mechanisms contributing to the development and maintenance of obesity and its 
complications, as well as potential points of therapeutic intervention for this disease. 
The effort to study and cure obesity is complicated by common misperceptions: 
that obesity is a cosmetic rather than a medical concern and that obesity is the result of 
personal shortcomings (i.e., poor self-control), rather than the result of biologically-
encoded processes.  Most “common” obesity likely results from complicated alterations 
in multiple gene products (to date, genome wide association studies (GWAS) have 
identified over 90 genetic regions that contain polymorphisms linked to the control of 
body weight) whose effects are unmasked by the ubiquitous availability of calories in 
modern society (5).  The recent modest success of a number of weight-loss drugs that 
modulate systems known to participate in body weight control suggests the utility of 
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more thoroughly understanding these systems to identify additional potential therapeutic 
targets.  
The principles underlying the control of body weight are straightforward: simply 
stated, homeostasis is achieved when the amount of energy consumed (by eating) 
equals that expended (by the combination of basal metabolic rate and physical activity).  
Increasing energy intake relative to energy expenditure results in positive energy 
balance and the storage of surplus calories as fat; negative energy balance is a result of 
decreasing food intake relative to energy expenditure (as in dieting) and decreases fat 
stores.  Both energy intake and energy expenditure are largely governed by the central 
nervous system (CNS); this is supported by the fact that the obesity-linked genes 
identified in monogenetic syndromes and in human GWAS studies are expressed in the 
CNS to a much larger degree than other physiologic systems(5).  Indeed, many of these 
genes have aided in the identification and analysis of the CNS circuits that control 
feeding and/or body weight(6).  As research uncovers the specific genes affecting 
bodyweight control, it is increasingly clear that many of these target genes are important 
for the development and regulation of neural circuits(5).  To further investigate these 
circuits, significant technological advancements have been made in genetic reagents 
that can be used in combination with more specified rodent models.  
 
Hypothalamic circuits regulate feeding behavior and overall energy balance 
Targeted chemical and electrolytic lesions of specific hypothalamic regions, including 
the ventromedial hypothalamus (VMH) and paraventricular nucleus of the hypothalamus 
(PVH), in rodents result in the rapid onset of robust obesity due to altered feeding 
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behavior and energy expenditure (7, 8).  Indeed, many of the genetic markers identified 
to play a role in bodyweight regulation in humans are expressed in the hypothalamus, a 
limbic region coordinating endocrine, metabolic, and autonomic responses (5).  While 
initial lesioning results suggested that the VMH in particular was the primary site 
coordinating satiety responses, more directed mechanical lesions or more specific 
genetic disruption of the PVH in mice and rats resulted in hyperphagic obesity, thus 
proving the PVH as the essential hypothalamic nucleus controlling feeding suppression 
(7, 9, 10).  Later studies determined this to be due, in part, to dense PVH innervation 
from the arcuate nucleus of the hypothalamus (ARC) (11-14).  ARC neurons lie 
adjacent to the median eminence (ME), a site near the base of the brain with permeable 
vasculature, and are positioned to detect circulating factors that convey information 
about peripheral energy stores.  For example, ARC neurons contain receptors for both 
leptin and ghrelin, hormones relaying information about adiposity levels and hunger, 
respectively (15).  ARC projections then transfer this information to the PVH, the 
primary hypothalamic output (Figure 5.1) (16, 17).  The significance of the PVH in 
coordinating these ARC signals with other hypothalamic inputs to mediate feeding 
suppression is underlined by the fact that PVH disruption results in substantial 
hyperphagic obesity (18). 
 The PVH is a heterogeneous nucleus containing both parvocellular and 
magnocellular populations.  Magnocellular PVH neurons are defined by both their size 
and direct projections to the posterior pituitary and are therefore capable of releasing 
neuropeptides immediately into the circulation.  Conversely, parvocellular PVH neurons 
project within the brain and fall into two categories: 1) endocrine PVH neurons 
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projecting to the median eminence and depositing neuropeptides into the hypophyseal 
portal system to regulate anterior pituitary function, and 2) PVH neurons projecting 
throughout the brain, including the hindbrain, that regulate a broad range of behaviors 
and autonomic responses.  Considerable research has focused on the neurosecretory 
PVH populations, since endocrine populations have distinct magnocellular or 
parvocellular electrophysiologic patterns that are commonly used to identify PVH cell 
types in brain slices, therefore providing valuable insight that relates neuronal 
physiology to endocrine function (19).  Yet, fewer studies to date have examined the 
role of centrally-projecting circuits in energy balance regulation. 
 
PVH control of energy balance and the melanocortin system 
In addition to historic lesioning studies that identified the PVH as an essential node in 
the control of bodyweight, recent genetic studies have highlighted the importance of this 
site.  Haploinsufficiency of Sim1, a transcription factor required for the development of 
the PVH (and the amygdala), results in an anatomically abnormal PVH and hyperphagic 
obesity in mice and humans (20, 21).  Energy balance control by the PVH is further 
highlighted by the dense expression of melanocortin 4 receptor (Mc4R), a necessary 
gene in feeding suppression and energy balance regulation (22).  Indeed, genetic 
alterations in Mc4R represent the most common monogenetic form of severe human 
obesity, underlying the phenotype of 1-2.5% of morbidly obese patients (23, 24).  This 
hyperphagic obesity phenotype is replicated in Mc4R knock-out rodent models (25). 
 The endogenous melanocortins capable of binding and regulating Mc4R activity 
arise from ARC neurons expressing either proopiomelanocortin (POMC) or agouti-
4
related peptide (AgRP) (26, 27).  Cleavage of the POMC peptide results in production of 
the anorexigenic α-MSH peptide, the predominant agonist of Mc4R (28). Conversely, 
separate ARC neurons release the orexigenic AgRP peptide, a Mc4R antagonist, in the 
PVH (26).  The importance of the melanocortinergic ARC-PVH circuit is demonstrated 
by both the necessity and sufficiency of Mc4R signaling in the PVH for normal feeding 
behavior (29-31).  Moreover, inhibition of PVH neuronal activity is consistently shown to 
be required for AgRP-induced feeding behavior (32, 33).  Furthermore, Mc4R re-
expression exclusively in neurons expressing Sim1, a transcription factor necessary for 
PVH development, in Mc4R-null mice normalizes feeding and reduces obesity by 60% 
(29).  The persistence of modest obesity following restoration of Mc4R expression in 
PVH cells suggests that the melanocortin-dependent regulation of energy expenditure is 
likely carried out by non-PVH Mc4R-expressing neurons, some of which are located in 
the hindbrain and express choline acetyltransferase (34). 
Although melanocortin signaling in the PVH does not appear to control energy 
expenditure, studies altering PVH function broadly suggest that the PVH controls 
sympathetic outflow (11, 35).  Certainly, energy expenditure is a critical component of 
homeostasis, since alterations in physical activity, thermogenesis, or basal metabolic 
rate (BMR) can affect adiposity.  However, defining the potential role of the PVH in 
energy expenditure regulation has been problematic since many genetic PVH 
alterations lead to robust obesity early in development, and assessments of energy 
expenditure in the obese state are complicated.  Therefore, it is difficult to ascertain if 
PVH alterations directly decrease energy expenditure, or if energy expenditure deficits 
following PVH manipulations are instead all a result of hyperphagic obesity.  Yet, 
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ablation of Sim1PVH neurons in adult animals decreases oxygen consumption prior to 
the onset of obesity, suggesting a role for the PVH in driving energy expenditure (36).  
 
PVH circuits regulating energy balance 
Neuronal subpopulations of the PVH 
Although the majority of research on the PVH has been performed in animal models, 
the same heterogenous PVH populations have been identified in the adult human PVH 
as well, suggesting the relevance of studies performed in rodents (37).  Large cells that 
make up the magnocellular PVH subdivision include those producing either arginine 
vasopressin (AVP) or oxytocin (OXT).  Release of OXT or AVP in the neurohypophysis 
is directly controlled by neuronal activity in response to physiologic stimuli (38).  
Specifically, AVP is released due to alterations in serum osmolality or peripheral blood 
pressure in order to ultimately increase renal water absorption and vasoconstriction 
(39).  While OXT can be co-released with AVP in the posterior pituitary due to blood 
pressure changes, it is primarily released in significant amounts during reproductive 
functions including parturition and lactation (19, 40).  
 Neurons producing corticotropin releasing hormone (CRH) are the primary 
parvocellular PVH population studied to date, since they coordinate the stress response 
through the hypothalamic-pituitary-adrenal (HPA) axis.  Briefly, secretion of CRH by 
CRHPVH neurons into the hypophyseal portal system at the median eminence causes 
portal transport into the anterior pituitary and a corresponding release of 
adrenocorticotropic hormone (ACTH) into the systemic circulation by pituitary 
corticotropes.  ACTH then acts on the adrenal glands to cause cortisol release (41).  
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Similar to CRH, parvocellular thyrotropin-releasing hormone (TRH) neurons in the PVH 
regulate the pituitary in order to stimulate thyrotropin-stimulating hormone (TSH) and 
prolactin release from the anterior pituitary to regulate metabolism and reproductive 
functions, respectively (42).  Additional parvocellular PVH populations capable of 
regulating ACTH production through the HPA axis likely include both OXT and AVP, 
though there is less understanding of how these neuropeptides affect anterior pituitary 
function (43).  
The characterization of centrally-projecting parvocellular PVH neurons continues 
to develop with the increasing number of research tools available to study individual 
PVH populations in rodent models.  Significant research has been performed on 
parvocellular OXT neurons, since centrally-administered OXT causes a variety of 
behavioral responses including decreased feeding, decreased anxiety-like behaviors, 
increased social behaviors, and decreased stress responses (44-47).  More recently, 
intranasal OXT administration has been studied in humans in an effort to treat diseases 
including autism, obesity, and obsessive-compulsive disorder (48-50).  Given the 
diverse functions associated with OXT action and the wide expression of OXT receptors 
(OXTR) throughout the brain, it is perhaps not surprising that the neurobiology of central 
OXT is particularly complex.  In relation to feeding regulation, OXT neurons are 
implicated as connectors between peripheral sensing neurons in the ARC and satiety 
centers in brainstem regions including the nucleus of the solitary tract (NTS).  Indeed, 
OXT peptide immunoreactivity (IR) can be detected in the NTS, a site with OXTR 
localization (51).  Furthermore, retrograde tracing studies employing fluorogold and 
cholera toxin B have identified OXTPVH neuronal projections to the NTS in the rat (52).  
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Some of these NTS-projecting OXTPVH neurons are activated following peripheral leptin 
treatment, further suggesting a role for these cells in conveying the ARC-PVH signal to 
the NTS and potentially signaling satiety (53).  Consistently, hyperphagic obese Sim1 
haploinsufficient mice demonstrate decreased Oxt expression (54, 55).   
While these studies suggest the importance of OXTPVH neurons in PVH-mediated 
control of energy feeding, OXT knock-out and OXT neuron ablation studies do not 
support these findings.  Specifically, elimination of the OXT or OXT receptor (OXTR) 
genes in mice has little effect on body weight regulation (56, 57).  In fact, these mice 
display only a slight enhancement of diet-induced obesity which is due to decreased 
energy expenditure, but not hyperphagia (57).  This lack of a feeding phenotype is not a 
consequence of developmental compensation, since genetic ablation of OXT neurons in 
adult mice produces similar results (58).  Moreover, the re-expression of Mc4R in OXT 
neurons fails to abrogate hyperphagia or obesity in Mc4R-null mice, suggesting that the 
control of feeding by the PVH and PVH melanocortin signaling is independent of OXT 
neurons (30).  Mc4RPVH neurons express little if any OXT, further supporting these 
findings (33).   
While centrally-projecting parvocellular PVH populations are diverse, AVPPVH and 
TRHPVH neurons are the only other PVH populations that have been shown to directly 
regulate energy balance.  Specifically, chemogenetic AVPPVH neuronal activation 
slightly decreases feeding, whereas driving TRHPVH neuronal activity results in 
increased food intake through activation of feeding circuits in the ARC (59, 60).  Less is 
known regarding the ability of CRHPVH neurons to control energy balance, since CRH is 
more widely produced throughout the brain therefore making it difficult to determine 
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PVH-specific CRH effects.  Moreover, CRH knock-out animals do not demonstrate a 
bodyweight phenotype (61).  Thus, while it is clear that central CRH administration is 
anorexigenic and thermogenic, it is not known if this is carried out by CRHPVH neurons 
(62, 63).  Furthermore, neither CRHPVH nor AVPPVH neuronal re-expression of Mc4R 
rescues the obesity due to knock-out of Mc4R (30). 
 
Intra-PVH connectivity: characterization of the PVH microenvironment 
As an essential node in the regulation of the stress response, PVH neurons are plastic 
and therefore capable of expressing combinations of neuropeptides in different 
physiologic paradigms.  While populations are considered to be mutually exclusive in 
the basal state, CRHPVH neurons can upregulate AVP expression in order to co-release 
AVP and CRH in context with decreased peripheral corticosteroid levels (64).  Although 
OXT release has been identified in the hypophyseal portal system, and is increased as 
a result of CRH administration, it is not clear if this is due to co-release of CRH and OXT 
from the same neurons following chronic stress (43, 65, 66).  Moreover, physiologic 
stressors can cause morphological plasticity in the PVH.  In particular, lactation causes 
alterations in dendritic branching in AVP and OXT neurons as well as changes in the 
excitatory and inhibitory inputs to these neurons (67-69).   
 The PVH is also highly interconnected, with multiple neuropeptide populations 
communicating with one another in a complex intra-PVH network.   This was originally 
discovered using Golgi staining methods that identified axonal collaterals between 
parvocellular PVH populations (70).  Further studies employed light and electron 
micrographic techniques to validate interconnected PVH populations, including CRHPVH 
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neurons that synapse on other PVH neurons (71-73).  More recently, electrophysiologic 
studies have characterized glutamatergic PVH interneuron populations capable of 
regulating other parvocellular PVH neurons (74, 75).  These excitatory PVH 
interneurons are required for the changes in magnocellular PVH neuronal activity 
observed in response to neurochemical inputs such as norepinephrine, orexin, and 
angiotensin as well as physiologic inputs such as restraint stress (75-78).  Similarly, 
parvocellular PVH neurons projecting to the spinal cord have been shown to receive 
glutamatergic input, likely from neurons within the PVH (79).   
Aside from axonal connections, PVH neurons also have the ability to release 
neuropeptides through dendrites, with dendritic processes extending within different 
PVH subnuclei (72, 80).  Microdialysis studies first demonstrated intranuclear AVP and 
OXT release in the PVH in various physiologic paradigms including stress responses 
and lactation (81, 82).  Furthermore, some of these stress-induced intra-PVH increases 
in AVP do not alter circulating levels of AVP, suggesting that the relevance of 
intranuclear neuropeptide release on local PVH circuits is independent of endocrine 
output (83).  Although these studies did not demonstrate direct dendritic neuropeptide 
release, further electrophysiologic studies employed caged NMDA strategies to confirm 
dendritic release of AVP on pre-sympathetic PVH populations (80).  Taken together, 
these studies suggest dense intra-PVH connectivity between glutamatergic PVH 
interneurons, neuropeptide populations, and pre-autonomic PVH outputs.       
 
Neuroanatomy of PVH outputs and energy balance control 
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The circuitry engaged by PVH populations enables it to control pituitary function, 
feeding and sympathetic output.  As previously mentioned, PVH projections to the 
median eminence and neurohypophysis regulate pituitary function.  PVH projections 
throughout the CNS are widely considered to be the relevant circuits for energy balance 
control.  Specifically, PVH projections to three sites are likely significant in these 
processes: hindbrain sites including the parabrachial nucleus (PBN) and NTS, and the 
intermediolateral column of the thoracic spinal cord (IML). 
 
Nucleus of the Solitary Tract (NTS) 
In general, the brainstem integrates neural and hormonal signals from the periphery, 
especially those derived from the gut.  The brainstem relays these signals to forebrain, 
hypothalamic, and cortical regions to coordinate appropriate behavioral and physiologic 
responses.  For the regulation of satiety, projections from the PVH to the NTS are of 
particular interest, since the NTS is anatomically close to the area postrema (AP), a site 
adjacent to the fourth ventricle that lacks a blood brain barrier.  The adjacent NTS is 
therefore the primary CNS site of visceral input as it receives both AP- and vagally-
derived gut signals of acute and chronic nutritional state, which it passes on to the 
dorsal motor nucleus of the vagus (DMV) to control gut motility and vagal reflexes (84).  
The NTS integrates both hypothalamic (through inputs from the PVH and, to a lesser 
extent, other hypothalamic sites) and vagal signals to coordinate the satiety response 
following ingestion of a meal.  The circuitry engaged by the NTS to achieve the satiety 
response is largely unknown, although direct glutamatergic projections to the PBN and 
reciprocal connections back to the PVH have the potential to play a role (85-90).   
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Although PVH-NTS projections are primarily thought of in the regulation of 
feeding behavior, the NTS also has the potential to regulate sympathetic activity, since it 
is also indirectly connected to brown adipose tissue (BAT) (91).  BAT is the primary 
driver of thermogenesis, and therefore a key contributor to basal metabolic rate (BMR) 
and overall energy expenditure.  Indeed, the NTS has also been shown to control 
sympathetic outflow, and more recently sympathetic outflow specifically to BAT (92, 93).  
Additionally, reciprocal connections back to the PVH, including onto spinally-projecting 
PVH neurons, could contribute to energy expenditure regulation by the NTS (94).  In 
fact, leptin-responsive ARC neurons regulate thermogenesis via the release of GABA 
into the PVH (95).  Moreover, this ARC-PVH regulation of energy expenditure appears 
to be modulated by NTS-projecting PVH neurons, therefore establishing at least one 
PVH circuit potentially regulating energy expenditure via the NTS (95).   
Although many neuroanatomical studies have aimed to identify the specific PVH 
populations projecting to the NTS, there still is not a clear consensus on the genetic or 
neuropeptide identity of NTS-projecting PVH neurons.  As mentioned above, retrograde 
tract tracing has resulted in conflicting results on whether OXTPVH neurons are a 
component of the PVH population capable of regulating NTS function.  In particular, 
whether OXT peptide expression in the NTS/DMV reflects fibers of passage or synaptic 
terminals is unclear, since many retrograde reagents used to identify the NTS/DMV 
innervation by OXTPVH neurons have been shown to infect fibers of passage (96, 97) 
(98).  Additionally, AVPPVH and CRHPVH neurons are consistently not identified upstream 
of NTS neurons (99, 100).  Moreover, although anatomical data shows projections to 
the NTS, channelrhodopsin-assisted circuit mapping (CRACM) techniques demonstrate 
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few glutamatergic PVH synaptic connections to the NTS (30, 33).  In contrast, similar 
CRACM experiments demonstrate that optogenetic activation of excitatory PVH 
neurons, including those containing Mc4R, in slices are capable of inducing direct 
excitatory post-synaptic currents (EPSCs) in neurons of the adjacent DMV (30, 33).  
Yet, in vivo optogenetic techniques show that Mc4RPVH neuronal projections to the 
NTS/DMV are unable to control feeding behavior (33).  Since PVH neurons project to 
both the NTS and DMV, and given the dense interconnectivity of these two adjacent 
regions, it is likely that PVH regulation of the NTS and DMV in the regulation of feeding 
and energy expenditure is more complex than originally thought. 
 
Parabrachial Nucleus (PBN) 
The PBN also integrates a variety of signals from the periphery and from other 
brainstem sites (e.g. periaqueductal gray (PAG), NTS) as well as the spinal column 
(101).  Although this circuit has been less studied than the PVH-NTS connection, 
retrograde tracing studies reveal PBN afferents from the PVH (88).  Moreover, PBN 
lesions result in hyperphagic obesity, suggesting the potential for PBN circuits as the 
primary output in PVH-regulated feeding suppression (102).  Moreover, direct 
projections from AgRP neurons to the PBN can control anorexia (103).  More recently, 
novel in vivo optogenetic studies displayed the ability of direct Mc4RPVH projections to 
the PBN to suppress feeding (33).  While this finding puts Mc4RPVH connections to the 
PBN at the forefront of research pertaining to PVH-mediated feeding suppression, it is 
still not established if other, non-Mc4R, PVH neurons project to the PBN in order to 
regulate feeding behavior.  
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Although the mechanism of PBN-induced feeding suppression is somewhat 
unknown, the PBN sends projections to sites throughout the brain implicated in feeding 
behavior including the ventromedial hypothalamus (VMH), central nucleus of the 
amygdala (CeA) and bed nucleus of the stria terminalis (BNST) (104-107).  Taken 
together, these data support a role for PVH-PBN connections in the PVH’s ability to 
control feeding behavior.  Conversely, little is known regarding the control of energy 
expenditure by the PBN.  Recent studies demonstrate the physiologic relevance of PBN 
projections to the VMH in controlling sympathetic output, but whether this connection 
controls energy expenditure is unknown (107, 108).   
 
Intermediolateral column of the spinal cord (IML) 
While the PVH clearly plays a critical role in the regulation of feeding behavior, much 
less is known about the potential control of energy expenditure by the PVH.  Studies 
have demonstrated PVH innervation of spinal cord regions, specifically in the thoracic 
IML, the main site of pre-ganglionic cholingergic neurons (i.e. expressing 
cholineacetyltransferase, ChAT) that regulate sympathetic outflow (16, 109, 110).  The 
majority of studies have used neuroanatomical approaches with the idea that 
projections to sites important for sympathetic outflow (e.g. IML) are likely functionally 
relevant as it pertains to energy expenditure regulation.  Initial studies aiming to 
determine whether the PVH is relevant for the control of thermogenesis used 
transsynaptic retrograde tracing reagents placed in BAT.  Indeed, PVH populations are 
indirectly connected to BAT, and therefore have the potential to regulate thermogenesis 
and overall energy expenditure in the Siberian hamster (91).  Although studies have 
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identified direct connections between the PVH and the IML, whether direct PVH-IML 
projections contact ChAT+ neurons projecting to and regulating BAT has yet to be 
formally demonstrated.   
In contrast with other PVH projection sites, some of the PVH populations 
projecting to the IML have been characterized.  This was demonstrated by co-labeling 
of both OXT and AVP IR-neurons with IML-projecting PVH neurons labeled by 
retrograde tracing reagents (99, 109).  More recently, studies demonstrated innervation 
of the IML by Mc4RPVH neurons (33).  While relatively sparse, the relevance of this 
connection is intriguing, since Mc4RPVH neuronal activation fails to alter energy 
expenditure in vivo (33).  
 
Inputs to and regulation of PVH neurons in energy balance control 
Aside from the well-characterized ARC-PVH circuit previously described, PVH neurons 
also receive input from sites throughout the hypothalamus, forebrain, and hindbrain.  
While few studies have tested the function of these inputs, it is nonetheless useful to 
consider the functional relevance of distinct circuits upstream of the PVH, since these 
circuits could ultimately provide information about the ability to manipulate discrete 
energy balance parameters (i.e. feeding vs. energy expenditure) through distinct 
regulatory circuits.  
 
Hypothalamic inputs to the PVH 
In general, the hypothalamus is essential for maintaining overall homeostasis, and 
therefore receives significant amounts of peripheral and central information regarding 
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an organism’s current physiologic environment.  To this effect, hypothalamic neurons, 
especially those within the ARC that are close to the median eminence, express a 
variety of receptors for circulating hormones and signals (e.g. leptin, ghrelin, glucagon-
like peptide, insulin, and serotonin) (15).  Given the dense innervation of the PVH by 
ARC populations, ARC input to the PVH is widely felt to be the primary circuit important 
for PVH-mediated feeding and energy balance control.  Yet, given the number of other 
hypothalamic inputs to the PVH, it is conceivable that other hypothalamic circuits control 
energy balance parameters via the PVH.  PVH input arises from other hypothalamic 
sites, including the VMH, DMH and LHA, which are capable of detecting peripheral and 
metabolic signals (90).  While receptors for most peripheral signals in these sites are 
less dense, receptors for leptin can be detected widely throughout all of these nuclei 
(111).  Similarly, the hunger-promoting hormone ghrelin is capable of regulating both 
LHA and VMH function (15).  These hypothalamic circuits also express a variety of 
metabolically-important receptors (e.g., Mc3/4R, cannabinoid receptors, CCK receptor) 
that are critical for feeding regulation (Figure 1.2) (15).   
While the neurochemical composition of these discrete hypothalamic inputs is not 
known, the functional significance of these circuits can be hypothesized based on a 
combination of historical lesioning studies combined with more recent genetic 
approaches.  In general, the DMH has been identified to regulate a variety of 
physiological processes also mediated by the PVH, including sympathetic output, 
feeding, the growth axis, and cardiovascular function (112).  DMH neurons terminate in 
the parvocellular PVH subdivisions that project to spinal cord regions, and therefore 
have the potential to regulate sympathetic output and energy expenditure (113-115).  
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Moreover, DMH neurons with direct PVH projections are activated following leptin 
treatment, and DMH leptin action is capable of increasing sympathetic tone to BAT, 
highlighting this pathway as a potential integrator of peripheral signals with PVH circuits 
controlling energy expenditure (116, 117).  
 The VMH is commonly associated with its control of autonomic outflow and the 
counterregulatory response (118).  While lesioning studies demonstrated conflicting 
results on the ability of the VMH to control feeding behavior, more recent studies 
employing genetic mouse models demonstrate the necessity of leptin signaling in the 
VMH in the prevention of diet-induced obesity (119).  While the obesity due to disruption 
of VMH signaling pathways is not to the same degree as that observed upon PVH 
manipulation, it seems reasonable that the VMH controls both feeding and energy 
expenditure (120, 121).  Glutamatergic VMH neurons project throughout the anterior 
and posterior PVH (122).  Since VMH manipulations consistently result in decreased 
sympathetic tone, it is conceivable that the excitatory VMH inputs to the PVH drive 
sympathetic output, though this has not been determined (123, 124). 
The PVH also receives robust innervation from the LHA, a site characterized for 
its role in reward processing mediated by the midbrain (125).  LHA lesions result in 
aphagia and bodyweight loss leading to the classification of the LHA as a feeding center 
(126).  However, recent optogenetic studies demonstrate the LHA as a heterogenous 
nucleus in feeding regulation since activation of GABAergic LHA neurons drives robust 
feeding whereas LHA glutamatergic neurons are capable of suppressing feeding (127, 
128).  In addition, LHA neurons are capable of dramatically increasing motivated 
behaviors such as locomotor activity (129-132).  LHA populations are heterogenous, 
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with multiple combinations of neuropeptide and neurotransmitter neuronal contents.  In 
particular, orexin neurons in the LHA have been implicated in regulating energy 
balance, since orexin drives feeding when injected in the CNS (133).  Specifically, 
orexin neurons in the LHA are synaptically connected to the PVH, and orexin infusion in 
the PVH increases both physical activity and feeding duration (77, 134).  Yet, the 
function of this and other LHA populations, including those producing neurotensin, 
melanin concentrating hormone, GABA, and glutamate, in the regulation of PVH outputs 
is still largely unknown.   
 
Forebrain inputs to the PVH 
Since the PVH is widely viewed as the main pre-autonomic hypothalamic output, non-
hypothalamic inputs to the PVH are often overlooked.  Yet, sites within the forebrain 
display dense connectivity with PVH neurons.  In particular, neurons throughout the bed 
nucleus of the stria terminalis (BNST) are routinely labeled upstream of PVH 
populations by retrograde tracing reagents including fluorogold and modified rabies 
virus(122, 125).  BNST populations are also heterogenous, with both excitatory and 
inhibitory neuronal populations.  While GABAergic BNST neurons have been shown to 
project within the hypothalamus, clarification is still needed on whether PVH innervation 
by the BNST originates from inhibitory or excitatory BNST neurons (127).  The BNST is 
also well characterized in the ability to control both appetitive and aversive responses 
(135).  Certainly, recent reports suggest the intersection of food intake and appetitive 
and aversive behaviors (33, 136, 137).  Therefore, while not well understood, BNST 
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connections to the PVH have the potential to integrate complex behaviors likely 
connected to feeding control. 
 
Hindbrain inputs to the PVH 
Although the majority of research on PVH circuitry is focused on PVH outputs to the 
brainstem, reciprocal connections from the hindbrain to the PVH have been described.  
The significance of these reciprocal connections in energy balance is largely unknown; 
however, it is tempting to consider that different populations of PVH neurons integrate 
these inputs and therefore coordinate an ultimate autonomic response depending on 
peripheral energy stores.  In particular, glutamatergic neurons of the PAG, PBN and 
zona incerta (ZI) project to the PVH (113, 138-142).  The function of zona incerta 
neurons is largely unknown, though it is possible that these neurons could supply the 
PVH with dopaminergic input, highlighting the potential for integration of motivational 
circuits with satiety and autonomic circuits in the PVH (143).  Though traditionally 
considered in the context of pain, PAG connections to the PVH provide an additional 
input capable of relaying information surrounding stress responses, and sympathetic 
output (144).  Additionally, catecholaminergic brainstem populations in the rostral 
ventrolateral medulla (RVLM) innervate parvocellular PVH populations, and are 
therefore capable of relaying sensory information in the control of sympathetic output 
(89).  Specifically, A1-A6 (noradrenergic) and C1-C3 (adrenergic) RVLM cell groups 
project throughout the PVH, though the specific populations innervated by these cell 
groups is largely unknown (145, 146) 
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GABA shell 
The PVH also receives local inhibitory input from a GABAergic shell surrounding the 
PVH.  These inputs help sustain a tonic inhibitory tone on magnocellular and 
parvocellular PVH neurons (70, 147-149).  Research to date on the function of these 
inhibitory inputs has primarily focused on regulation of the HPA axis, demonstrated by 
altered endocrine responses and increased CRH neuronal activity following 
pharmacologic administration of GABA receptor antagonists in the PVH (150, 151).  
Retrograde tracing studies identified innervation of pre-autonomic PVH neurons by 
neurons within the GABA shell, demonstrating the potential for the GABA shell to 
regulate PVH energy balance circuits (152).  The GABA shell also has the potential to 
serve as an intermediary between the PVH and cortical structures that do not have 
direct PVH projections (150). 
 
Future Directions 
A molecular and cellular understanding of the mechanisms used by PVH circuits to 
control energy balance has advanced significantly in recent years, largely due to the 
development of novel rodent models used in combination with in vivo tools, including 
chemogenetic and optogenetic reagents.  Yet, this new framework underlines additional 
questions regarding the capability and necessity of PVH neuronal subsets to regulate 
distinct energy balance parameters.  The possibility to dissect the circuitry and function 
of neuronal subpopulations in the PVH provides an opportunity to characterize the 
component parts of a complex nucleus that is essential for obesity prevention.  Although 
the anatomical structure of parvocellular and magnocellular PVH subnuclei has long 
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been characterized, the understanding of how these different PVH structures coordinate 
physiologic outputs is unknown.  For this reason, it is crucial to identify and interrogate 
PVH neurocircuitry through the analysis of PVH subsets.  The understanding of PVH 
subpopulation projection targets and upstream inputs will allow for the understanding of 
how multiple components of neural circuits used by the PVH control feeding 
suppression and/or sympathetic output.  Moreover, identifying PVH markers that are 
functionally relevant in the control of distinct aspects of energy balance has the potential 
to highlight novel markers that could contribute to the development of more targeted 
therapeutics.  Since the PVH is not uniform in nature, therapeutic intervention of the 
entire heterogenous PVH might have broad side effects that offset the desired energy 
balance changes.  Therefore, the careful dissection of genetically-defined PVH circuits 
and their necessity or sufficiency in energy balance parameters is pertinent. 
    Recent studies have characterized the importance of Mc4RPVH neurons 
projections to the PBN in mediating the satiety response (33).  Moreover, Mc4RPVH 
neurons are necessary for obesity prevention through feeding suppression (29, 30).  
While significant research has been performed on the Mc4RPVH population, less has 
been focused on non-Mc4RPVH neurons.  Certainly, Mc4R re-expression on CRH, OXT, 
or AVP neurons is not sufficient to rescue the obesity phenotype of Mc4R null mice (30).  
Yet, the connectivity of these non-Mc4RPVH neuronal populations, both with one another 
and outside of the PVH is not understood.  Furthermore, significant research suggests 
that OXTPVH neurons might control feeding energy expenditure (32, 53).  Additionally, 
since centrally-projecting AVP, OXT and CRH PVH populations comprise just 25% of 
PVH neurons, it is likely that unidentified PVH neurons are capable of regulating energy 
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balance parameters(109).  Furthermore, control of energy expenditure by the PVH is 
often overlooked due to the clarification of Mc4RPVH neuronal function in feeding, but not 
energy expenditure (29, 33).  While spinal cord projections from PVH populations 
suggest the possibility for PVH-regulated sympathetic outflow, the physiologic role of 
distinct PVH neurons in energy expenditure is largely unstudied (109).  
 To address some of these issues, we employed genetic mouse models in 
combination with anterograde and retrograde tracing reagents to investigate the circuitry 
of PVH neuronal subsets in energy balance control.  First, we characterized the role of a 
novel PVH subset expressing neuronal nitric oxide synthase (Nos1) in the regulation of 
both feeding and energy expenditure.  Furthermore, we clarify the circuitry and 
capability of OXTPVH neurons, a subset of the Nos1PVH field, to control both feeding and 
energy expenditure parameters.  We then identify a unique genetic marker, insulin 
receptor substrate 4 (IRS4) and test the sufficiency and necessity of the IRS4PVH 
neuronal population in bodyweight regulation.  Lastly, we characterize projection-
specific inputs to OXTPVH, IRS4PVH, Nos1PVH, or Sim1PVH neurons in order to identify 
upstream modulators of NTS-projecting, PBN-projecting, or IML-projecting PVH 
neuronal subsets. Overall, we demonstrate that genetic dissection of PVH cell types 
allows for assessment of the functional relevance of PVH neurons in energy balance 
parameters.  We superimpose these questions with circuit analyses of both downstream 
targets and potential upstream modifiers to ultimately construct circuit maps that engage 
PVH subsets projecting to disparate hindbrain or spinal cord sites. 
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Figure 1.1 ARC-derived hypothalamic signals are integrated by the PVH. The 
arcuate nucleus (ARC) sits adjacent to the third ventricle (3V) and detects circulating 
signals of energy balance (including leptin via its receptor, LepRb).  A variety of ARC 
populations express LepRb, including distinct energy balance neurons containing 
propiomelanocortin (POMC) or agouti-related peptide (AgRP).  Leptin activates the 
anorexigenic POMC neurons while inhibiting the orexigenic AgRP neurons; both send 
dense projections to the PVH, where they mediate crucial signals to control feeding and 
energy balance.  The ARC also contains other (non-AgRP, non-POMC) PVH-projecting 
neurons, some of which also express LepRb.  The PVH integrates these ARC-derived 
signals with other information and represents the primary hypothalamic output to other 
brain regions for the control of energy balance.  
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Figure 1.2. Upstream regulators of PVH circuits.  The major hypothalamic input to 
the PVH originates in the arcuate nucleus (ARC).  In addition to these inputs, PVH 
neurons receive information from other hypothalamic sites including the dorsomedial 
hypothalamus (DMH) and ventromedial hypothalamus (VMH). Both the DMH and VMH 
contain a variety of receptor populations for both central and peripheral signals and are 
therefore poised to relay a variety of information to the PVH to modulate parameters of 
energy balance.  Consistent with the notion of the PVH as an integrating center, many 
nonhypothalamic regions project to the PVH, including sites in the forebrain [bed 
nucleus of the stria terminalis (BNST), preoptic area (POA), amygdala] and the 
hindbrain [periaqueductal gray (PAG), parabrachial nucleus (PBN), nucleus of the 
solitary tract (NTS)].   
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Chapter II 
Control of food intake and energy expenditure by Nos1 neurons of the 
paraventricular hypothalamus1 
 
 
Introduction 
The paraventricular nucleus of the hypothalamus (PVH) is the major autonomic output 
area of the hypothalamus and is critical for energy homeostasis.  Loss of one copy of 
single-minded 1 (Sim1), a key transcription factor regulating PVH development, disrupts 
PVH maturation and function, resulting in hyperphagic obesity with associated glucose 
dysregulation in mammals (1, 2).  Similar metabolic derangements also result from 
electrolytic destruction of the PVH (3, 4).  In addition, the PVH serves as an important 
regulatory center for peptidergic signals and physiologic parameters known to modulate 
food intake, including leptin, melanocortins, and dehydration (5, 6).  Indeed, the 
melanocortin pathway is essential for energy balance in mammals and is directly linked 
to PVH function.  Leptin-responsive neurons in the arcuate nucleus (ARC) project to the 
PVH, a site of dense melanocortin receptor expression, and release melanocortin 
agonists and antagonists/inverse agonists to modulate PVH function (6, 7).  Consistent 
with its role in feeding, the PVH sends dense projections to hindbrain regions such as
																																																								
1	Chapter II was previously published in the Journal of Neuroscience: Sutton AK, Pei H, 
Burnett KH, Myers MG Jr., Rhodes CJ, Olson DP. Control of food intake and energy 
expenditure by Nos1 neurons of the paraventricular hypothalamus. Journal of 
Neuroscience, 2014; 34(46):15306-18. 	
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the nucleus of the solitary tract (NTS) and parabrachial nucleus (PBN) to modulate 
feeding behavior (8-10).  Although PVH functions are understood in broad terms, the 
specific cell types within this heterogeneous structure that regulate feeding are not fully 
defined.   
In addition to modulating feeding, a variety of data suggest that PVH neurons 
control energy expenditure.  For example, infusion of the melanocortin receptor agonist 
MTII into the PVH increases energy expenditure (6), while ablation of Sim1 neurons 
throughout the central nervous system decreases metabolic rate (11).   Furthermore, 
polysynaptic retrograde tracing links thermogenic brown adipose tissue to the PVH 
through the sympathetic nervous system via cholinergic, preganglionic neurons in the 
intermediolateral column of the thoracic spinal cord (ChATIML) (12).  Similar to the PVH 
cells that control feeding, the neurochemical identity of the PVH neurons regulating 
energy expenditure via the sympathetic nervous system (SNS) has yet to be 
established. 
Given the role of the PVH in energy balance, we sought to identify subsets of 
Sim1PVH neurons that contribute to energy homeostasis and reveal their roles in food 
intake or energy expenditure.  We discovered that Nos1PVH neurons are a subset of 
Sim1PVH neurons and send dense projections to hindbrain regions important for feeding 
control and to the upper thoracic spinal cord that regulates sympathetic output.  
Moreover, Nos1PVH neuron activation regulates both feeding and energy expenditure, 
indicating the critical importance of Nos1PVH neurons in PVH-regulated energy balance.  
In addition, OXTPVH neurons represent a subset of Nos1PVH neurons that project to and 
modulate ChATIML neurons, yet make only a small contribution to energy balance.  
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These studies demonstrate discrete roles for Nos1PVH and OXTPVH neurons in energy 
balance and position these neurons anatomically and functionally in the neural circuitry 
of energy balance. 
 
 
Materials and Methods 
 
Experimental Animals 
 
Oxytocin-ires-Cre (OXT-iCre), Nos1-ires-Cre (Nos1-iCre) and Sim1-Cre mice were 
generated as described previously (13-15).  Adult male mice (8-12 weeks old) were 
used for all studies.  OXT-iCre, Nos1-iCre or Sim1-iCre mice were bred to a Cre-
dependent GFP reporter line (16) to fluorescently label Cre-expressing PVH 
subpopulations. All animals were bred and housed within our colony according to 
guidelines approved by the University of Michigan Committee on the Care and Use of 
Animals.  Unless otherwise noted, mice were provided ad libitum access to food and 
water.  
 
Stereotaxic injections 
OXT-iCre, Nos1-iCre, Sim1-Cre and non-transgenic (WT) mice were given pre-surgical 
analgesia and anesthetized with isofluorane.  Mice were placed in a digital stereotaxic 
frame (Model 1900, Kopf Instruments) and the skull was exposed.  Intracranial injection 
coordinates were determined from Bregma using the stereotaxic atlas of Paxinos and 
Franklin (17).  Viral injections were performed using a pressurized picospritzer system 
coupled to a pulled glass micropipette (coordinates from bregma: A/P: -.500, M/L: +/- 
.220, D/V: -4.800).  For tract tracing experiments, 50-150 nl of the adenoviral 
39
synatophysin-mCherry terminal tracer (Ad-iN/syn-mCherry, (18)) was unilaterally 
injected in Sim1-Cre, Nos1-iCre or OXT-iCre mice.  Additionally, stereotaxic injection of 
Red Retrobeads (RR) (Lumafluor) was performed in the NTS of Sim1-Cre and Nos1-
iCre mice with a Cre-dependent GFP reporter (lox-GFP).  Control mice also received 
unilateral injection of RR in order to determine PVH-NTS connections using OXT 
peptide staining.  For NTS injections, mice were anesthetized and placed in the digital 
stereotax.  The fourth ventricle was identified and used as a geographic landmark to 
determine the site of injection.  A glass micropipette was lowered into the site (D/V: -
.630) and ~25nl of RR was injected.  For functional analysis of PVH neurons, bilateral 
PVH injections of AAV-hM3Dq-mCherry (AAV-hM3Dq, purchased from UNC Vector 
Core) were performed in Sim1-Cre (50nl/side), Nos1-iCre (50 nl/side) and OXT-iCre (75 
nl/side) mice.  To control for viral transduction, non-transgenic (WT) mice also received 
bilateral injections of AAV-hM3Dq (75 nl/side).  Mice injected with the Ad-iN/syn-
mCherry tracer were individually housed for five days following injection to allow for viral 
transduction and protein transport before perfusion, whereas mice injected with RR 
were perfused after seven days following injections.   Mice injected with AAV-hM3Dq 
were allowed to recover for seven days following surgery before further experiments 
were performed. 
 
Food Intake Measurements 
Following recovery, Nos1-iCre, OXT-iCre, Sim1-Cre, and WT mice with bilateral PVH 
AAV-hM3Dq injections were given PBS (i.p.) for three consecutive days to allow for 
injection acclimatization.  Prior to assessment, mice were fasted during the light cycle 
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(9:00-18:00) and had ad libitum access to water.  Mice were then injected with vehicle 
(10% (2-Hydroxypropyl)-b-cyclodextrin, Sigma #C0926) at the onset of feeding (18:00) 
and food intake was measured at 2 hours, 4 hours, and 16 hours (overnight) post 
injection.  The following day, mice were injected with CNO at the onset of feeding (0.3 
mg/kg in 10% b-cyclodextrin) and food intake was measured at 2 hours, 4 hours, and 16 
hours following injection.   
 
Energy Expenditure Measurements 
Energy expenditure was measured using the Comprehensive Laboratory Monitoring 
System (CLAMS, Columbus Instruments) in the University of Michigan’s Small Animal 
Phenotyping Core to obtain multi-parameter analysis including open circuit calorimetry 
and activity via optical beam breaks.  AAV-hM3Dq injected mice were acclimatized to 
the sealed chambers for two days with free access to food and water.  The 
experimentation room had 12-12 hours dark-light cycles (18:00-6:00) and the 
temperature was maintained at 20-23°C.  On experimental days (Day 3 and Day 4), 
food was removed at 9:00 and vehicle (Day 3) or CNO (Day 4, 0.3 mg/kg) was injected 
at 11:00.  Food was then replaced at the onset of the dark cycle (18:00).  Although 
measurements (oxygen consumption (VO2), carbon dioxide production (VCO2), and 
spontaneous motor activity) were carried out throughout the duration of the experiment, 
data shown is averaged VO2 or activity over the four hours following injection of vehicle 
or CNO.  
 
Intrascapular Temperature Measurements 
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University of Michigan’s Small Animal Phenotyping Core placed temperature 
transponders (IPTT-300 model with corresponding DAS-7007R reader, Bio Medic Data 
Systems, Inc) in the intrascapular subcutaneous tissue directly above brown adipose 
tissue under isofluorane anesthesia.  Mice were allowed to recover for 14 days before 
testing.  On the day of testing, food was removed from the cages at 9:00 AM.  Two 
hours later, mice with PVH-directed AAV-hM3Dq injections were injected with vehicle or 
CNO and temperatures were recorded prior to injection and at 15, 30, 60, and 120 
minutes following injection.    
 
Perfusion and Immunohistochemistry (IHC) 
For tract tracing experiments, mice were perfused five days (Ad-iN/syn-mCherry) or 
seven days (RR) after intracranial injection.  At the end of the neuronal activation 
studies, mice with bilateral AAV-hM3Dq injections were either treated with vehicle or 
CNO and perfused 90 minutes later as described previously (19).  Briefly, mice were 
deeply anesthetized with an overdose of pentobarbital (150 mg/kg, IP) and 
transcardially perfused with sterile PBS followed by 10% neutral buffered formalin or 4% 
paraformaldehyde (for perfusions with spinal cord removal).  Brains and spinal cords 
were removed, post-fixed, and dehydrated in 30% sucrose before sectioning into 30 µm 
slices on a freezing microtome (Leica).  Coronal brain sections were collected in four 
representative sections whereas longitudinal thoracic spinal cord sections were 
collected in three representative sections and stored at -20°C.  For Fos 
immunohistochemistry (IHC), free floating brain and spinal cord sections were 
pretreated with 30% H2O2 to remove endogenous peroxidase activity and then blocked 
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with normal goat or donkey serum and incubated in primary antibody overnight (rabbit 
anti-cFos 1:10,000, Calbiochem PC38).  Detection of primary antibody was performed 
by avidin-biotin/diaminobenzidine (DAB) method (Biotin-SP-conjugated Donkey Anti-
Rabbit, Jackson Immunoresearch, 1:200; ABC kit, Vector Labs; DAB reagents, Sigma).  
hM3Dq and choline acetyltransferase (ChAT) were detected using with primary 
antibodies for red fluorescent protein (RFP) (rat 1:2000, Allele Biotechnology) and ChAT 
(spinal cords only; goat, 1:500, Millipore AB144P) respectively followed by secondary 
immunofluorescence detection with donkey anti-rat-Alexa 568 or donkey anti-goat-Alexa 
488 (1:200, Invitrogen).  For PVH colocalization experiments, IHC immunostaining was 
performed using primary antibodies for GFP (rabbit 1:20,000, Invitrogen A6455, nNos1 
(sheep 1:2500, (20), kindly provided by Dr. Vincent Prevot), or oxytocin (rabbit 1:2500, 
Peninsula Laboratories T-4084).  For tract tracing experiments, immunostaining was 
performed using primary antibodies for RFP, GFP or oxytocin.  
 
Immunoblotting of BAT UCP1 protein 
Sim1-Cre, OXT-iCre and WT mice with bilateral PVH AAV-hM3Dq injections were given 
either vehicle or CNO and 90 minutes later mice were anesthetized with pentobarbital 
and BAT was removed, frozen on dry ice and stored in -80°C.  Tissue was 
homogenized in protein lysis buffer (10% SDS, 1M Tris, pH 6.8, 12.7 mM EDTA) with 
metal beads in a Bullet blender for 30 minutes.  Samples were clarified by centrifugation 
and protein concentration was quantified by BCA assay (Thermo Scientific, cat. 
#23225).  Lysates were diluted to equal protein concentration in lysis buffer plus 1X 
NuPage SDS buffer (Invitrogen) with 2.5% 2-mercaptoethanol.  Samples were boiled for 
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5 minutes and loaded on a SDS gradient polyacrylamide gel (Invitrogen) and separated 
by electrophoresis.  Proteins were transferred to Immobilon PVDF membranes 
(Millipore) and Ponceau staining of membranes was used to confirm equal protein 
loading between lanes.  Membranes were blocked in 5% milk for 1 hour at room 
temperature and then incubated with primary antibodies in 5% BSA (goat anti-UCP1, 
1:2000, Santa Cruz Biotechnology #SC-6528); rat anti-α-Tubulin, 1:1000, Thermo 
Scientific MA1-80017), and appropriate HRP-conjugated secondary antibodies (1:5000 
dilution in 5% milk, IgG peroxidase; GE Healthcare).  Super Signal enhanced 
chemiluminescence (Pierce) was used for visualization by autoradiography and bands 
were quantified by densitometry.         
 
Statistical Analysis 
Paired t-tests, unpaired t-tests, or repeated measures two-way ANOVAs were 
calculated using GraphPad Prism.  Significance was determined for p<0.05.  
 
Results 
nNos1 (Nos1) expression defines a PVH subpopulation 
 Nos1 in situ hybridization (Allen Brain Atlas) and Nos1-iCre, lox-GFP reporter mice 
demonstrate the existence of NOS1-containing neurons in the PVH.  To determine if 
NOS1 peptide marks a neuronal subset of the entire PVH, we stained brains from Sim1-
Cre, lox-GFP reporter mice for GFP and NOS1 immunoreactivity (-IR) and found that all 
Nos1PVH neurons express Sim1, but not all Sim1PVH neurons express NOS1 (Figure 
2.1A, 1B).  PVH cell counts in Sim1-Cre, lox-GFP brain slices immunostained for Nos1 
peptide (n=5) revealed that Nos1PVH neurons account for ~21% of the Sim1PVH field.  To 
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identify some potential Nos1PVH subtypes, we also investigated the overlap between 
Nos1PVH and oxytocin (OXT)-expressing PVH neurons.  Using Nos1-iCre, lox-GFP 
sections, we found that almost all OXTPVH neurons (~90%, n=3) contain GFP, whereas 
only 16% (n=3) of Nos1-iCrePVH neurons contain OXT peptide.  This confirms that 
OXTPVH neurons are a subset of Nos1PVH neurons (Figure 2.1C, 1D).  This establishes 
that Nos1PVH neurons represent a discrete subset of Sim1PVH neurons and that most 
OXTPVH neurons lie within the Nos1PVH field (Figure 2.1E).  Given the importance of 
Sim1PVH neurons in energy balance regulation and the limited information regarding the 
roles of specific PVH subtypes in this regulation, we investigated the potential 
contributions of Nos1PVH and OXTPVH neurons to the control of energy balance 
parameters. 
 
Nos1PVH neurons send dense projections to hindbrain regions important for satiety 
As hindbrain regions (eg., NTS/DMV, PBN and specifically PVHàNTS neuronal 
projections) have been implicated in feeding regulation, we characterized efferent 
projections from defined PVH subpopulations to the NTS/DMV and the PBN.  We used 
Sim1PVH neurons as a reference group to establish projection targets for comparison 
with Nos1PVH and OXTPVH subsets.  Sim1-Cre mice were unilaterally injected with a Cre-
dependent adenoviral synaptophysin-mCherry tracer (Ad-iN/syn-mCherry, Figure 2.2A), 
which traffics predominantly to synaptic terminals and preferentially identifies projection 
terminals as opposed to axons of passage.  We observed dense Sim1PVH neuron-
derived mCherry-IR (Figure 2.2B) in hindbrain regions important for satiety, including 
the medial and lateral PBN (mPBN and lPBN, respectively, Figure 2.2C) and the NTS 
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(Figure 2.2D).  Similar mCherry-IR was observed in these hindbrain regions from 
Nos1PVH neurons injected with Ad-iN/syn-mCherry (Figure 2.2F, 2G, 2H).  In contrast, 
we detected very little OXTPVH-derived syn-mCherry in the PBN (Figure 2.2K) or NTS 
(Figure 2.2L).  Unilateral PVH injections of Ad-iN/syn-mCherry in OXT-iCre mice 
demonstrated syn-mCherry expression (red) only in OXTPVH neurons (green; Figure 
2.2J), confirming the fidelity of the Cre-dependent Ad-iN/syn-mCherry virus.  As 
expected, Sim1PVH, Nos1PVH, and OXTPVH neurons also sent dense projections to the 
median eminence, reflecting the parvocellular PVH subpopulation projections that 
influence pituitary function and the magnocellular projections that release their contents 
directly from the posterior pituitary into the systemic circulation (Figure 2.2E, 2I, 2M). 
 To better characterize the PVH neurons that project to the NTS/DMV and 
potentially affect feeding behaviors, we injected fluorescent latex microspheres 
(Lumafluor Red Retrobeads, RRs) unilaterally in the NTS of Sim1-Cre, lox-GFP, Nos1-
iCre, lox-GFP and wildtype mice (Figure 2.3A, 3E, 3J, respectively).  RRs are 
preferentially taken up by pre-synaptic terminals at the site of injection and undergo 
retrograde transportation back to the cell body, thus allowing neuron identification by 
autofluorescence.  As might be expected, all RR-labeled PVH neurons from Sim1-Cre, 
loxGFP animals co-express GFP, suggesting that all PVHàNTS projections originate 
from Sim1PVH neurons (Figure 2.3B-D).  Retrograde labeling from the NTS/DMV in 
Nos1-iCre, lox-GFP mice also demonstrates extensive (but not complete) overlap 
between NTS-projecting RR labeled neurons and Nos1PVH neurons (Figure 2.3F-H).  
Since previous reports suggest the presence of OXTPVH projections to the NTS/DMV 
and essentially all OXTPVH neurons are within the Nos1-iCrePVH field, we co-stained 
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Nos1-iCre, lox-GFP mice with NTS RR injections for OXT peptide (Figure 2.3II- 3IIV).  As 
expected, OXT-IR is seen within Nos1PVH neurons (Figure 2.3IV, green, open 
arrowheads), however NTS-injected RR predominantly labeled Nos1PVH neurons that do 
not contain OXT (white arrowheads).  In agreement with these findings, very few 
OXTPVH cell bodies were labeled with NTS-injected RRs (Figure 2.3J-M) in separate 
control mice, even though OXT peptide (green) was detectable in the NTS/DMV at the 
site of the RR injection (Figure 2.3J).  This suggests that much of the OXT-IR in the 
NTS identifies fibers of passage, as opposed to synaptic terminals.  Nevertheless, it is 
the non-OXT Nos1PVH neurons that comprise the bulk of the NTS-projecting Nos1PVH 
neurons.   
 
Nos1PVH and OXTPVH neurons project to the spinal cord 
Since sympathetic outflow promotes energy expenditure and the PVH is implicated in 
energy expenditure regulation, we also investigated whether Nos1PVH and OXTPVH 
neurons project to hindbrain and spinal cord regions important for sympathetic nervous 
system (SNS) control (6, 11).  The raphe pallidus (RPa) is an important hindbrain region 
controlling brown adipose tissue (BAT) function and energy expenditure (12, 21, 22).  
We found few syn-mCherry terminals originating from Sim1PVH (Figure 2.4A), Nos1PVH 
(Figure 2.4B) or OXTPVH (Figure 2.4C) neurons in the RPa.  To determine if Sim1PVH, 
Nos1PVH and OXTPVH neurons project to the preganglionic, sympathetic output neurons 
of the thoracic spinal cord, we also examined longitudinal spinal cord sections from 
Sim1-Cre, Nos1-iCre or OXT-iCre mice following unilateral PVH Ad-iN/syn-mCherry 
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injections.  We identified robust syn-mCherry tracer in thoracic spinal cord regions 
originating from Sim1PVH (Figure 2.4D), Nos1PVH (Figure 2.4E), and OXTPVH neurons 
(Figure 2.4F).  Syn-mCherry-IR is localized in close proximity to neurons expressing 
choline acetyltransferase (ChAT) in the intermediolateral column of the thoracic spinal 
cord (ChATIML), suggesting potential Sim1PVH, Nos1PVH and OXTPVH neuronal 
connections with and regulation of IML pre-ganglionic sympathetic neurons (Figure 
2.4D’, 4E’, 4F’).   
  
Temporal control of PVH neuronal subpopulations 
Having established the anterograde projection targets for Sim1PVH, Nos1PVH and 
OXTPVH neurons, we tested the physiologic effects of acute activation of these PVH 
neurons on feeding and energy expenditure.  To selectively activate these PVH 
subsets, we employed Designer Receptors Exclusively Activated by Designer Drugs 
(DREADDs) technology (23).  The hM3Dq DREADD is a modified human muscarinic 
receptor designed to couple with stimulatory Gq-proteins.  Binding of an otherwise inert, 
synthetic ligand CNO (clozapine N-oxide) activates neurons expressing hM3Dq.  This 
system has been engineered to be Cre recombinase-dependent in order to achieve cell-
specific control (Figure 2.5A).  Thus, site-specific injection of a Cre-dependent adeno-
associated virus (AAV)-hM3Dq allows for remote and temporal activation only of 
neurons that express Cre recombinase.  As for our tracing studies, we used Sim1-Cre 
mice to target the majority of PVH neurons and establish an upper threshold of PVH 
“output capacity” upon DREADDs activation followed by Nos1PVH and OXTPVH subset 
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activation.  As a control for DREADD injection, bilateral PVH injections of AAV-hM3Dq 
into wildtype (WT) mice were also performed.  
Although AAV-hM3Dq was primarily limited to the PVH of Sim1-Cre injected 
mice, there was a small amount of AAV-hM3Dq expression in Sim1-Cre+ areas in the 
anterior hypothalamus (Figure 2.5B).  Similarly, while injections in Nos1-iCre mice were 
targeted for the PVH, some Nos1-iCre+ neurons in the thalamus also expressed hM3Dq 
(Figure 2.5C).  Importantly, any injected Nos1-iCre animals that expressed hM3Dq in 
peri-PVH areas implicated in feeding (i.e., DMH) were excluded from the analysis.  PVH 
injections of AAV-hM3Dq were restricted to OXTPVH neurons, as Cre expression in OXT-
iCre mice is limited to the PVH and SON (Figure 2.5D).   Using nuclear Fos staining as 
an indicator of neuronal activation, vehicle injection caused little PVH activation in Sim1-
Cre (Figure 2.5E), Nos1-iCre (Figure 2.5F), or OXT-iCre (Figure 2.5G) mice with 
bilateral PVH AAV-hM3Dq injections.  In contrast, hM3Dq-injected mice treated with 
CNO prior to perfusion demonstrated a marked increase in nuclear Fos staining in 
transduced PVH neurons (Figure 2.5H-J).  Specifically CNO-stimulated PVH nuclear 
Fos expression in Sim1-Cre + AAV-hM3Dq mice (176.5 ± 6.5 vs. 51.0 ± 6.0 (vehicle); 
n=2 each, unpaired t-test, t(2)=14.2, p=0.005), Nos1-iCre + AAV-hM3Dq mice (200.7 ± 
39.0 vs. 36.0 ± 5.0 (vehicle); vehicle n=2, CNO n=3, unpaired t-test, t(3)=3.3, p=0.047) 
and OXT-iCre + AAV-hM3Dq mice (130 ± 14 vs. 63.0 ± 5.1 (vehicle); n=4 each, 
unpaired t-test, t(6)=4.4, p=0.005). This demonstrates that cell-specific DREADD 
expression allows for temporal control of PVH neuron activity.  Nuclear Fos was also 
apparent in non-Cre expressing cells suggesting that PVH subtypes can activate 
neighboring PVH cells via local connections (Figure 2.5J inset) (24, 25).  We detected 
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no hM3Dq expression or CNO-dependent activation in the PVH of wild type control mice 
(data not shown).   
 
Direct activation of PVH neurons alters food intake  
Based on our anterograde tracing of PVH subsets, we hypothesized that activation of 
Sim1PVH and Nos1PVH neurons would alter feeding (via projections to hindbrain regions).   
To test this hypothesis, we injected AAV-hM3Dq bilaterally into the PVH of Sim1-Cre, 
Nos1-iCre and OXT-iCre mice and treated these animals with CNO (0.3 mg/kg) at the 
onset of dark cycle feeding.  Body weights of the animals used in these studies are as 
follows (BW ± SEM): Sim1-Cre 22.6g ± 1.6g (n=4), Nos1-iCre 25.6g ± 0.7g (n=8), OXT-
iCre 22.8g ± 0.8g (n=10), WT 24.1g ± 0.8g (n=4).  Wild type controls with bilateral PVH 
AAV-hM3Dq injections showed no change in feeding behavior in response to CNO 
compared to vehicle injections, demonstrating that neither viral transduction nor CNO 
alone altered food intake (Figure 2.6A, first panel).  Activation of Sim1PVH neurons 
robustly suppressed feeding as compared to vehicle control (Figure 2.6A, second panel, 
paired t-test, t(3)=5.0, p=0.015).  As hypothesized, Nos1-iCre mice with bilateral AAV-
hM3Dq injections also ate significantly less following CNO-activation of Nos1PVH 
neurons as compared to vehicle (Figure 2.6A third panel, paired t-test, t(7)=7.9, 
p<0.0001).  Interestingly, the suppression of two hour food intake following activation of 
Sim1PVH and Nos1PVH neurons is comparable (t(10)=1.0, p=0.35, unpaired t-test), 
suggesting that the anorexia associated with Sim1PVH activation is mediated largely via 
Nos1PVH neurons.   The anorectic effect of Nos1PVH activation persists through four 
hours of re-feeding (paired t-test, t(7)=11.2, p<0.0001) (there is a similar trend for 
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Sim1PVH neuron activation, Figure 2.6B), although total overnight food intake (16 hours) 
approximates controls (Figure 2.6C).  In contrast to Sim1PVH and Nos1PVH neurons, 
activation of OXTPVH neurons had little effect on two or four-hour food intake (Figure 
2.6A, 6B, fourth panel).  Thus Nos1PVH neuron activation suppresses feeding to a similar 
extent as Sim1PVH neurons, suggesting a major role for Nos1PVH neurons in the control 
of food intake.  Furthermore, since activation of the OXT-containing subset of Nos1PVH 
neurons fails to blunt feeding, the activation of non-OXT Nos1PVH neurons must be 
required for this effect. 
 
Activation of PVH neurons increases Fos expression in sympathetic output neurons and 
promotes energy expenditure 
The role of the PVH in modulating energy expenditure has received less attention than 
its contribution to feeding regulation.  Given the robust spinal cord projections from 
Sim1PVH, Nos1PVH and OXTPVH neurons, we determined the effect of DREADD-
mediated activation of these PVH neural subsets on nuclear Fos expression in 
preganglionic, sympathetic output neurons and overall oxygen consumption.  First, we 
treated Sim1-Cre +AAV-hM3Dq, Nos1-iCre +AAV-hM3Dq or OXT-iCre +AAV-hM3Dq 
mice with vehicle (Figure 2.7A, 7C, 7E) or CNO (Figure 2.7B, 7D, 7F) and analyzed 
thoracic spinal cord sections for nuclear Fos accumulation in ChATIML neurons.  Acute 
activation of Sim1PVH, Nos1PVH and OXTPVH neurons all appeared to increase nuclear 
Fos expression in ChATIML neurons relative to vehicle control.  To estimate this effect, 
we determined the percentage of ChATIML neurons containing nuclear Fos 
immunoreactivity in thoracic spinal cord sections from Sim1-Cre + AAV-hM3Dq mice in 
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response to CNO vs. vehicle.  Activation of Sim1PVH neurons showed a trend towards 
increased nuclear Fos expression in ChATIML neurons with 42.6 + 7.2 % (CNO-treated) 
vs. 16.1 + 5.4% (vehicle treated) ChATIML neurons counted (n=2 each; unpaired t-test, 
t(2)=2.9, p=0.099). These data thereby suggest a potential neuroanatomical pathway for 
the regulation of sympathetic output and energy expenditure.  
 To determine the ability of each PVH subset to modulate energy expenditure, we 
used metabolic cages to measure oxygen consumption (VO2) and locomotor activity in 
animals expressing hM3Dq in Sim1PVH, Nos1PVH and OXTPVH neurons.  Activation of 
Sim1PVH neurons and Nos1PVH neurons increased average oxygen consumption in the 
absence of food (Figure 2.8A, 8B, second and third panels) (Sim1: paired t-test, 
average 4hr VO2 t(3)=8.8, p=0.003, average 4hr VO2 LBM t(3)=11.0, p=0.002; Nos1: 
average 4hr VO2 t(3)=3.2, p=0.05, average 4hr VO2 LBM t(3)=3.6 p=0.038).  Acute 
activation of OXTPVH neurons also significantly increased oxygen consumption (Figure 
2.8A, 8B, fourth panel) (average 4hr VO2 t(9)=2.4, p=0.042, average 4hr VO2 LBM 
t(9)=2.3, p=0.05), albeit not to the extent seen with activation of Nos1PVH neurons 
(unpaired t-test of average change in 4hr VO2, t(13)=2.5, p=0.029).  Baseline oxygen 
consumption was elevated in the initial cohort of OXT-iCre +AAV-hM3Dq mice in 
comparison to other groups (One-way ANOVA of average change in 4hr VO2, 
F(3,19)=7.3, p=0.002).  To exclude the possibility that this elevated baseline O2 
consumption was a property of the OXT-iCre transgenic line as opposed to a cohort 
effect, oxygen consumption experiments were repeated in a second cohort of mice 
naïve to CNO (Figure 2.8C, 8D).  Indeed, OXT-iCre +3Dq mice treated with vehicle had 
the same baseline oxygen consumption as WT and OXT-iCre mice without 3Dq (One-
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way ANOVA of average change in 4hr VO2, F(2,9)=1.0, p=0.4), indicating that OXT-iCre 
mice are not metabolically compromised.  Interestingly, activation of any of the PVH 
subpopulations increased average total activity, although not equally (Figure 2.8E; 
paired t-test Sim1+3Dq: t(3)=4.7, p=0.019; Nos1+3Dq: t(3)=26.8, p=0.0001; OXT+3Dq: 
t(9)=4.3, p=0.002).  As expected, WT+AAV-hM3Dq mice showed no change in oxygen 
consumption or activity in response to CNO (Figure 2.8A-E).  Body weights of the 
animals used in these studies are as follows (BW ± SEM): Sim1-Cre 30.5g ± 2.1g (n=4), 
Nos1-iCre 29.4g ± 0.9g (n=4), OXT-iCre +3Dq cohort 1 23.9g ± 0.6g (n=10), WT cohort 
1 26.3g ± 1.3g (n=4), OXT-iCre +3Dq cohort 2 28.9g ± 1.3g (n=4), OXT-iCre (no 3Dq) 
28.1g ± 1.8g (n=4), WT cohort 2 30.4g ± 1.6g (n=4).  Therefore, Nos1PVH or OXTPVH 
neuron activation promotes locomotor activity and overall energy expenditure, although 
to a lesser extent than that seen with pan-PVH activation.  Unlike the feeding effects 
observed with Nos1PVH activation, Nos1PVH-driven increases in VO2 and activity were 
significantly smaller than those seen with Sim1PVH activation (unpaired t-test of average 
4hr VO2, F(3,3)=1.062, p=0.009; unpaired t-test of average 4hr activity, F(3,3)=274.3, 
p=0.023), suggesting that both Nos1PVH and non-Nos1PVH subsets of Sim1 neurons 
contribute to the control of energy expenditure.  As increased locomotor activity may 
contribute to overall energy expenditure and oxygen consumption (VO2), we analyzed 
VO2 in Sim1-Cre + AAV-hM3Dq and Nos1-iCre + AAV-hM3Dq mice for at timepoints 
when locomotor activity was approximately matched before and after CNO treatment 
(Figure 2.8F).  While this analysis revealed a trend towards increased VO2 for both 
Sim1-Cre + AAV-hM3Dq and Nos1-iCre + AAV-hM3Dq animals when matched for 
activity (Sim1-Cre, paired t-test, t(3)=2.4, p=0.093; Nos1-iCre, paired t-test, t(3)=2.9, 
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p=0.064), the magnitude of the effect was small relative to the overall increase in VO2.  
This suggests that increased locomotor activity contributes significantly to the increased 
oxygen consumption observed with PVH stimulation, but that changes independent of 
locomotor activity may also play a role.   
 
Acute Sim1PVH activation increases intrascapular BAT temperature 
Since the activation of PVH neurons tends to increase energy expenditure in mice 
matched for locomotor activity and Sim1PVH, Nos1PVH and OXTPVH neurons send dense 
projections to pre-ganglionic sympathetic ChAT neurons in the thoracic spinal cord, we 
hypothesized that activation of these PVH subpopulations might promote 
thermogenesis in addition to potentially playing a role in locomotor activation.  To test 
this, temperature transponders were placed in the subcutaneous tissue directly above 
intrascapular BAT in Sim1-Cre +hM3Dq, OXT-iCre +hM3Dq and WT +hM3Dq mice and 
intrascapular temperatures (TIS) were measured before and after PVH neuron 
activation.  Body weights of the animals used in these studies are as follows (BW ± 
SEM): Sim1-Cre 27.4g ± 1.6g (n=3), OXT-iCre 28.5g ± 0.8g (n=4), WT 31.5g ± 1.2g 
(n=5).  Activation of Sim1PVH neurons increased TIS when compared to baseline TIS 
before injection of vehicle or CNO (Figure 2.9A, 9B; Repeated measures two-way 
ANOVA of change in baseline TIS F(1,2)=102.9, p=0.010 with Sidak multiple 
comparisons post-hoc test 15-min t(8)=4.2, p=0.016; 30-min t(8)=8.3, p=<0.001; 60-min 
t(8)=6.5, p=0.001; 120-min t(8)=5.3, p=0.004).  Additionally, activation of OXTPVH 
neurons display a trend of increased TIS, though this did not reach statistical 
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significance.  TIS in WT +hM3Dq mice were not altered in response to CNO 
administration.   
 Since acute PVH activation increased TIS, we determined if this was mediated by 
increased BAT uncoupling protein 1 (UCP1), the primary facilitator of BAT 
thermogenesis (26).  We examined UCP1 protein levels in BAT from Sim1-Cre +AAV-
hM3Dq, OXT-iCre +AAV-hM3Dq, or WT+AAV-hM3Dq mice treated with either vehicle 
or CNO.  UCP1 protein levels did not change in response to Sim1PVH or OXTPVH 
neuronal activation when normalized to the loading control (Figure 2.10).  Therefore, 
increases in TIS following PVH activation may be via mechanisms that increase UCP1 
activity rather than protein levels (27, 28).          
 
Discussion 
The importance of the PVH in feeding regulation, energy balance and endocrine and 
autonomic function is well established (6, 8, 15).  However, a detailed understanding of 
the cellular and neural pathways used by the PVH to regulate these physiologic 
functions has been complicated by the heterogeneity of this nucleus and the inability to 
investigate specific PVH cell populations independently.  To tackle these issues, we 
combined Cre-dependent viral vectors with PVH cell-specific Cre drivers to probe the 
function of discrete PVH neuron subsets and explore their connectivity with brain 
regions known to be involved in energy homeostasis.  
 The hypothalamic transcription factor Sim1 marks PVH neurons involved in 
feeding regulation.  Sim1-restricted melanocortin-4 receptor (Mc4R) expression in an 
otherwise Mc4R-null background corrects the associated hyperphagia of Mc4R-null 
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mice and targeted ablation of Sim1 neurons in the CNS results in hyperphagia and 
altered energy expenditure (11, 15).  Sim1 neurons lie in other brain areas, but most if 
not all PVH neurons express Sim1 (1).  We now show that acute activation of Sim1PVH 
neurons suppresses feeding and increases energy expenditure and activity, highlighting 
the ability of PVH neurons to regulate both energy balance parameters and validating 
our experimental system.  To clarify the neurochemical identity and neural circuitry of 
the PVH neurons mediating these effects, we identified and utilized Nos1 expression to 
mark a specific Sim1PVH subset.  Our tracing studies revealed dense Nos1PVH 
projections to hindbrain and spinal cord structures involved in energy balance 
regulation.  Using a pharmacogenetic approach, we showed that activation of Nos1PVH 
neurons suppressed food intake at the onset of feeding to an extent that is comparable 
to that observed upon activation of the entire Sim1PVH field.  These experiments 
therefore establish Nos1PVH neurons as an important Sim1PVH subset in feeding 
regulation.   
 OXTPVH neurons are a subset of Nos1PVH neurons and pharmacologic evidence 
has demonstrated the ability of hindbrain OXT action to suppress feeding, suggesting a 
role for OXTPVH neurons in anorectic signaling by the PVH (9, 29, 30).  In contrast, 
however, genetic inactivation of OXT or its receptors minimally impacts feeding, and 
ablation of OXT neurons in adult mice neither alters feeding nor the anorexic response 
to a melanocortin agonist (13, 31, 32).  In order to determine the contribution of OXTPVH 
neurons to Nos1PVH-regulated feeding, we subjected OXTPVH neurons to Cre-dependent 
synaptic tracing and pharmacogenetic analysis.  DREADD-mediated activation of 
OXTPVH neurons failed to suppress feeding under normal conditions.  Therefore, while 
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Nos1PVH neurons mediate a powerful anorectic signal, the OXT-expressing subset of 
Nos1PVH neurons cannot account for this effect, thus revealing a requisite role for non-
OXT Nos1PVH neurons in food intake control. 
The role of the PVH in energy expenditure regulation has received less attention 
than its role in food intake control.  Sim1 haploinsufficiency or manipulation of Mc4R 
expression in Sim1 neurons alters feeding, but minimally affects energy expenditure 
(15, 33).  Selective ablation of Sim1 neurons in the CNS, however, lowers oxygen 
consumption, suggesting a role for Sim1 neurons in the regulation of both food intake 
and energy expenditure (11).  Indeed, recent data reveal that glutamatergic signaling in 
Sim1 neurons contributes to energy expenditure regulation (34).  In this study, we show 
that direct activation of Sim1PVH neurons increases energy expenditure and that both 
Nos1PVH and OXTPVH neurons contribute to this physiologic response.  Using a novel 
anterograde viral tracing tool, we did not find significant projections to the RPa.  
However, we did identify dense terminals from Sim1PVH, Nos1PVH and OXTPVH neurons 
in close proximity to ChATIML neurons of the thoracic spinal cord, a cholinergic 
preganglionic structure that regulates sympathetic output.  Importantly, direct activation 
of Nos1PVH and OXTPVH neurons appears to stimulate ChATIML cells concomitant with 
increases in metabolic rate, locomotor activity, and thermogenesis.  This physical 
connection between PVH neuron subsets and ChATIML neurons provides a potential 
neuroanatomical mechanism by which sympathetic output may be increased to promote 
energy expenditure following activation of these PVH neurons.  Indeed, activation of 
Sim1PVH neurons increases intrascapular temperature overlying BAT.   As 
thermogenesis requires BAT UCP1 (35) and there is no change in UCP1 protein 
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expression following Sim1PVH stimulation, this effect is likely dependent on a change in 
UCP1 activity.  
The increase in oxygen consumption upon Sim1PVH activation is more robust 
than that seen with activation of either Nos1PVH or OXTPVH neurons alone.  Interestingly, 
the extent of ChATIML activation is relatively similar, suggesting that additional CNS 
pathways are engaged to regulate energy expenditure acutely.  Only an estimated 25% 
of hindbrain and spinal cord-projecting PVH neurons have been neurochemically-
defined (8).  Therefore, other, unidentified PVH neurons likely play important roles in 
modulating energy expenditure.  Additional studies directed at identifying and 
manipulating chemically-defined populations of PVH neurons will be critical in 
understanding the cellular and neuroanatomical pathways used by the PVH to modulate 
energy expenditure and achieve energy homeostasis.  
The neurotransmitters by which Nos1PVH and OXTPVH neurons regulate feeding 
and energy expenditure remain undefined.  It is likely that both neuropeptides and fast-
acting neurotransmitters such as glutamate, the predominant PVH neurotransmitter, 
contribute to PVH-mediated energy balance.  Indeed, Sim1 glutamate signaling is 
important for overall control of energy balance (34).  Our DREADD activation studies 
suggest the possibility that PVH neurons regulate adjacent cells.  Given the presence of 
local, intra-PVH glutamatergic connections, it is conceivable that PVH neuronal subsets 
can recruit certain neighboring cell types to affect functional outputs (24).   
Overall, our dissection of PVH neuron subpopulations reveals that specific 
subsets of PVH neurons play distinct roles in energy balance regulation.  Specifically, 
we reveal a role for Nos1PVH neurons in the control of feeding, and that this function 
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requires the participation of non-OXT Nos1PVH neurons.  Moreover, both Nos1PVH and 
the OXTPVH neurons project to sympathetic output areas of the thoracic spinal cord and 
are capable of increasing energy expenditure (although to a lesser extent than Sim1PVH 
neurons, suggesting roles for non-Nos1 Sim1PVH cells). The identification and analysis 
of other PVH subpopulations will be crucial to determining the molecular mechanisms 
by which the PVH regulates energy homeostasis. 
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Figure 2.1.  Neuronal nitric oxide synthase 1 (Nos1) marks a subset of PVH 
neurons.  A, B) Immunohistochemistry (IHC) for NOS1 peptide (red) in the PVH of 
Sim1-Cre, lox-GFP reporter mice (lox-GFP, green) identifies Nos1PVH neurons as a 
Sim1PVH neuronal subset.  C, D) OXTPVH neurons are contained within the Nos1PVH 
population (green), as shown by expression of OXT (red) in sections from Nos1-iCre, 
lox-GFP mice.  (E) A model of neurochemically-defined cell types within the PVH.  
Dashed boxes indicate regions that are digitally enlarged and shown as insets.  
Arrowheads indicate representative overlapped cell-bodies.  Scale bar =200 µm, 
3V=third ventricle. 
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Figure 2.2.  Nos1PVH neurons project to hindbrain regions important for satiety.  A) 
A Cre-dependent synaptophysin-mCherry viral vector allows for anterograde-tracing of 
projections in the CNS.  B) Unilateral PVH-specific injections of Ad-iN/syn-mCherry in 
Sim1-Cre mice identify projections to the parabrachial nucleus (C), nucleus of the 
solitary tract (D), and the median eminence (ME) (E).  F) Stereotaxic injection of Ad-
iN/syn-mCherry in the PVH of Nos1-iCre mice demonstrates similar projections to the 
PBN (G), NTS (H), or ME (I).  In contrast, injection of Ad-iN/syn-mCherry in the PVH of 
OXT-iCre mice (J) reveals few projections to either the PBN (K) or NTS (L), though 
projections to the ME are readily apparent (M).  Sections were co-stained for OXT 
peptide (green) to show the fidelity of the Cre-dependent virus (J).  Dashed boxes 
indicate regions that are digitally enlarged and shown as insets.  Scale bar in D, H, 
L=200 µm, scale bar in all others=500 µm.  3V=third ventricle, mPBN, lPBN=medial, 
lateral parabrachial nucleus, respectively, scp=superior cerebellar peduncle, AP=area 
postrema, NTS=nucleus of solitary tract, cc=central canal, ME=median eminence. 
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Figure 2.3.  Retrograde labeling of PVH neurons from the NTS.  Red Retrobeads 
(RR) were injected in the hindbrains of in Sim1-Cre, lox-GFP (A) or Nos1-iCre, lox-GFP 
(E) mice to identify NTS projecting Sim1PVH (B, C, D) and Nos1PVH (F, G, H) neurons. 
Additional sections from Nos1-iCre, lox-GFP mice with hindbrain RR injections (same 
injection shown in E) were stained for OXT peptide (Fig. 3IIII) and show RR-labeled 
Nos1 neurons do not contain OXT peptide (Fig. 3IIV white arrowheads).  OXT neurons 
only co-localize with Nos1, but not RR (Fig. 3IIV, open arrowheads).  Furthermore, RR 
injected in the NTS of control mice (J) do not colocalize with OXT peptide (green) in the 
PVH (J-M).  At the site of injection, beads appear in both green and red channels due to 
bead intensity (note yellow injection site).  Immunohistochemistry identifies OXT peptide 
(green) expression near injection site (J).  Dashed boxes indicate regions that are 
digitally enlarged and shown as insets.  Arrowheads indicate representative overlapped 
cell-bodies.  Scale bar in A, E, J=500 µm, all other scale bars=200 µm.  AP=area 
postrema, cc=central canal, 3V=third ventricle. 									
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Figure 2.4.  Nos1PVH and OXTPVH neurons project to pre-ganglionic neurons in the 
spinal cord.  A) Sim1-Cre, B) Nos1-iCre, or C) OXT-iCre mice with unilateral Ad-
iN/syn-mCherry injections (red) show few projections to the raphe pallidus (RPa).  In 
contrast, Sim1PVH (D), Nos1PVH (E) and OXTPVH (F) all innervate thoracic spinal cord 
regions in close proximity to cholinergic neurons of the intermediolateral column 
expressing choline acetyltransferase (ChAT, green, D’, E’, F’). Scale bars in A-C=500 
µm, scale bars in D-F=200 µm.  cc=central canal, RPa=raphe pallidus.         																
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Figure 2.5.  DREADDs allow for remote and temporal control of PVH neuronal 
activity.  A) Diagram of the Cre-dependent hM3Dq Designer Receptor Exclusively 
Activated by Designer Drugs (DREADDs) expression vector.  Expression of AAV-
hM3Dq-mCherry in the PVH of Sim1-Cre (B), Nos1-iCre (C), or OXT-iCre (D) mice is 
detected by immunohistochemistry (IHC).  Sim1-Cre (E), Nos1-iCre (F), or OXT-iCre 
(G) mice with bilateral AAV-hM3Dq injections demonstrate little nuclear Fos 
immunoreactivity after treatment with vehicle.  In contrast, PVH neurons expressing 
hM3Dq are activated following injection of CNO (H, I, J).  OXTPVH neuronal activation 
leads to nuclear Fos expression (J, inset, green) not only in hM3Dq-expressing OXTPVH 
neurons (J inset, red, closed arrowheads), but also in neighboring non-OXTPVH neurons 
(open arrowheads).  Scale bar in B-D=1 mm, scale bar in E-J=200 µm.  oc=optic 
chiasm, PVH=paraventricular nucleus, SON=supraoptic nucleus. 
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Figure 2.6.  Acute activation of Nos1PVH neurons suppresses feeding.  WT +AAV-
hM3Dq, Sim1-Cre +AAV-hM3Dq, Nos1-iCre or OXT-iCre +AAV-hM3Dq mice were 
injected with vehicle (white bars) or CNO (black bars).  Activation of Sim1PVH or Nos1PVH 
neurons decreases A) 2-hour food intake whereas activation of OXTPVH neurons had no 
effect on food intake.  Activation of Nos1PVH neurons also significantly decrease 4-hour 
food intake (B), and Sim1PVH neuronal activation shows a similar trend, though this is 
not significant.  Cumulative overnight food intake (16hr) is not altered by activation of 
PVH neuronal subsets (C).  Average values ± SEM are shown, *p<0.05, ***p<0.01, 
****p<0.0001 compared to vehicle values  (WT n=5, Sim1-Cre n=4, Nos1-iCre n=8, 
OXT-iCre n=10).  Significance was determined using two-tailed paired t-test. 
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Figure 2.7.  Nos1PVH and OXTPVH neurons can activate ChATIML neurons.  While 
basal neuronal activity of ChATIML neurons is minimal in Sim1-Cre +AAV-hM3Dq (A), 
Nos1-iCre +AAV-hM3Dq (C) or OXT-iCre +AAV-hM3Dq (E) mice injected with vehicle, 
CNO-mediated activation of Sim1PVH (B), Nos1PVH (D) or OXTPVH (F) neurons increases 
nuclear Fos (green) in IML ChAT neurons (red).  All scale bars=200 µm.  Dashed white 
boxes identify regions where 40X inset images were taken.  Arrowheads indicate 
representative overlapped cell-bodies and Fos-IR nuclei upon treatment with CNO.    All 
scale bars=200 µm.  cc=central canal. 
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Figure 2.8. Acute activation of Nos1PVH neurons increases energy expenditure.  
WT +AAV-hM3Dq, Sim1-Cre +AAV-hM3Dq, Nos1-iCre or OXT-iCre +AAV-hM3Dq mice 
were injected with vehicle (white bars) or CNO (black bars).  Activation of Sim1PVH, 
Nos1PVH or OXTPVH neurons increases average oxygen consumption (A, B) and total 
activity (E) over four hours following injection.  A second cohort of CNO-naïve mice also 
shows a trend towards increased 4-hour average VO2 in response to activation of 
OXTPVH neurons, while baseline VO2 is unchanged in comparison to WT+3Dq or OXT-
iCre mice without 3Dq injections (C, D) (WT n=5, Sim1-Cre n=4, Nos1-iCre n=4, OXT-
iCre cohort 1 n=10, WT cohort 2 n=4, OXT-iCre +3Dq cohort 2 n=4, OXT-iCre n=4).  To 
determine potential activity-independent changes in VO2, VO2 was determined in Sim1-
Cre +3Dq and Nos1-iCre +3Dq (F) mice before and after CNO treatment, at time points 
when locomotor activity was approximately matched at activity levels below a threshold 
value of 300 counts/hr (bars indicate average values ± SEM, line segments indicate 
individual mice; Sim1 n=4, Nos1 n=4).  Average values ± SEM are shown, *p<0.05, 
**p<0.01, ***p<0.001 compared to vehicle values.  Significance was determined using 
two-tailed paired t-test within groups or unpaired t-test between groups. 							
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Figure 2.9. Acute activation of Sim1PVH neurons increases subcutaneous 
intrascapular temperature.  Sim1-Cre +3Dq, OXT-iCre +3Dq and WT+3Dq mice 
received temperature transponders in the subcutaneous intrascapular tissue directly 
above brown adipose tissue (BAT).  Intrascapular temperature (TIS) was measured 
before and after vehicle or CNO administration. TIS is shown relative to baseline TIS 
before and after injection of vehicle or CNO (A, dashed and solid lines, respectively) 
and also represented as peak area under the curve (B).  Average values ± SEM are 
shown, *p<0.05, **p<0.01, ***p<0.001 compared to vehicle values (WT n=5, Sim1-Cre 
n=3, OXT-iCre n=4).  Significance was determined using repeated measures two-way 
ANOVA with Sidak multiple comparisons post-hoc test.  													
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Figure 2.10. Acute activation of PVH neurons does not alter BAT UCP1 protein 
expression.   BAT protein lysates were prepared from Sim1-Cre +3Dq and OXT-iCre 
+3Dq mice treated with either vehicle or CNO for 90 minutes.  UCP1 protein levels are 
no different following Sim1PVH (A, left) or OXTPVH (A, right) activation with CNO in 
comparison to vehicle.  B) Quantification of BAT UCP1 protein levels relative to the 
loading control, α -tubulin.  (Sim1 +vehicle (veh), n=2; Sim1 +CNO, n=2; OXT +veh, 
n=3; OXT +CNO n=2). 	
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Chapter III 
 
Paraventricular hypothalamic IRS4 neuronal activity is required for energy 
 
homeostasis 
 
Introduction 
As information increases regarding the genetic variability associated with common 
obesity, it is clear that genetic polymorphisms affecting neural function and architecture 
in the central nervous system (CNS) are disproportionately correlated with obesity (1).  
Within the brain, the paraventricular nucleus of the hypothalamus (PVH) is a primary 
hypothalamic node essential for relaying information to non-hypothalamic structures in 
the hindbrain and spinal cord that control satiety and energy expenditure (2-4).  Critical 
signals of overall energy balance to the PVH originate in the arcuate nucleus (ARC) 
from neurons that produce melanocortin agonists (α-MSH) or antagonists (AgRP) that 
ultimately act on melanocortin 4 receptors (Mc4R) in the PVH (5-9).  Dysregulation of 
the entire PVH with site-directed lesions or inhibition of PVH Mc4R action using genetic 
mouse models both lead to similar levels of obesity (10-12).  However, while obesity 
resulting from the disruption of PVHMc4R activity is entirely due to hyperphagia, lesions of 
the entire PVH result in dysregulation of both feeding and energy expenditure (12-14).  
Moreover, the genetic identity of the Mc4R-containing PVH population remains elusive, 
since it is clear that Mc4R action in the PVH cannot be ascribed to neural populations 
expressing oxytocin (OXT), vasopressin (AVP), or corticotropin-releasing hormone 
(CRH)(12).
83
  While significant research has examined the role of Mc4RPVH neurons in the 
control of feeding behavior, it is clear that the role of the PVH in energy balance 
regulation is more complex than originally understood.  PVH neurons are predominantly 
glutamatergic and highly interconnected, partly by PVH interneurons that may 
coordinate neural activity between PVH subpopulations, including OXT and AVP (15-
17).  The genetic identity of these connections and their significance in the functional 
control of PVH neuron populations is largely unknown.  We have previously shown the 
capacity of a PVH population containing neuronal nitric oxide synthase 1 (Nos1PVH) to 
reduce feeding upon chemogenetic activation (chapter II).  The Nos1PVH population 
represents a relatively large percentage of PVH neurons as determined by Cre-
dependent reporter labeling (~70%), and therefore may likely include both interneurons 
and parvocellular PVH populations projecting to hindbrain and spinal cord sites.  The 
OXTPVH neuronal population is almost entirely contained within the Nos1PVH field; it is 
capable of driving small changes in energy expenditure, but is not a component of the 
PVH’s ability to suppress feeding.  While this uncovers a role for non-OXT Nos1PVH 
neurons in the control of feeding, it is imperative to characterize the connectivity and 
role of smaller PVH subsets on the control of both feeding and energy expenditure in 
order to identify and understand potential targets for obesity.  With this in mind, we 
characterized a non-OXT, non-Nos1PVH, population expressing insulin receptor 
substrate 4 (IRS4) in the PVH that projects to both hindbrain and spinal cord regions. 
Surprisingly, IRS4PVH neuronal activity is necessary for normal feeding and bodyweight, 
but not energy expenditure, suggesting a functional role for multiple PVH populations in 
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the control of feeding behavior and energy expenditure.  Additionally, we discovered 
that NTS-projecting and PBN-projecting IRS4PVH neurons both receive dense 
innervation from local, non-IRS4, PVH neurons, supporting a role for an interconnected 
PVH network in the regulation of energy balance.   Overall, our study proposes a novel 
framework for the regulation of bodyweight through multiple interconnected PVH 
populations that are, perhaps, independently capable of controlling distinct energy 
balance parameters including feeding and energy expenditure. 
 
 
Materials and Methods 
 
Experimental Animals 
 
IRS4-ires-Cre (IRS4-iCre) mice were generated using methods previously described 
(18).  Briefly, genomic DNA including the 3’ UTR of the murine Irs4 gene was PCR 
amplified from R1 ES cells and cloned into a plasmid for insertion of an Frt-flanked 
neomycin selection cassette followed by an internal ribosomal entry sequence fused to 
a Cre recombinase transgene (iCre) between the STOP codon and the polyadenylation 
site.  Constructs were linearized and electroporated into R1 ES cells by the University of 
Michigan Transgenic Animal Model Core.  Correctly targeted ES cells were identified by 
quantitative real-time PCR and Southern blots and then injected into C57Bl/6J 
blastocysts to generate chimeric animals.  Chimeras were then bred to C57Bl/6J 
females to confirm germline transmission and generate the IRS4-neo-iCre mice.  To 
remove the frt-flanked neo cassette, IRS4-neo-iCre mice were then bred to Flp deleter 
mice (Jax 012 930).   
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Adult male mice (8-12 weeks old) were used for all studies. IRS4-iCre mice bred 
to a Cre-dependent GFP reporter line to fluorescently label Cre-expressing IRS4 
neurons resulted in germline recombination of loxP sites and subsequent ectopic GFP 
expression (19).  When mice still containing the neo selection cassette (IRS4-neo-iCre) 
were crossed to lox-GFP mice germline recombination was not detected and IRS4PVH 
neurons could be visualized.  All animals were bred and housed within our colony 
according to guidelines approved by the University of Michigan Committee on the Care 
and Use of Animals.  Unless otherwise noted, mice were provided ad libitum access to 
food and water.  All mice were acclimatized to intraperitoneal (i.p.) injections three days 
prior to any experimental i.p. injection.  
 
Generation of Cre-dependent rabies helper virus 
TVA-2A-B19G was PCR amplified from the pAAV-EF1-TVA-B19G-GFP plasmid 
(Addgene #26197) and cloned into the TOPO cloning vector.  SpeI and SacI restriction 
sites were added to the PCR product via TOPO and used to insert the product into the 
pAAV-hSyn-Flex vector (20) .   
 
Generation of modified rabies virus 
EnvA- ΔG-mCherry and EnvA- ΔG-GFP were generated in the University of Michigan 
viral vector core using conditions previously described (21, 22).   
 
Stereotaxic injections 
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Stereotaxic injections were performed in IRS4-iCre and non-transgenic (WT) mice as 
previously described (Chapter II).  Briefly, mice were placed in a digital stereotaxic 
frame (Model 1900, Kopf Instruments) under isofluorane and provided with pre-surgical 
analgesia. Viral injections were performed using a pressurized picospritzer system 
coupled to a pulled glass micropipette (coordinates from bregma: PVH: A/P= -.500, 
M/L= +/- .220, D/V= -4.800). For tract tracing experiments, 50 nl of the adenoviral 
synatophysin-mCherry terminal tracer (Ad-iN/syn-mCherry, (23)) was unilaterally 
injected in IRS4-iCre mice. For functional analysis of IRS4PVH neurons, bilateral PVH 
injections of AAV-Flex-hM3Dq-mCherry (AAV-Flex-hM3Dq, purchased from UNC 
Vector Core), AAV-DTA (Patrick Fuller, Harvard Medical School), AAV-Flex-TetTox 
(purchased from the Stanford Viral Vector core) or control injections of AAV-Flex-GFP 
were performed in IRS4-iCre or WT mice (50 nl/side). For analysis of monosynaptic 
upstream inputs to IRS4PVH neurons, IRS4-iCre mice were unilaterally injected with 
AAV-Flex-TVA-B19G in the PVH and allowed to recover for at least 21 days to ensure 
adequate helper virus expression throughout both cell bodies and terminals. Mice then 
underwent a second surgery with dual stereotaxic injections into ipsilateral PVH 
projection targets with rabies-GFP in the PBN (A/P=-4.770, M/L=+/- 1.35, D/V=-2.8) and 
rabies-mCherry injected into the NTS.  NTS injections were performed as previously 
described, whereby the fourth ventricle was identified and used as a geographic 
landmark to determine the site of injection (Sutton AK).  A glass micropipette was 
lowered into the site (D/V: -.550) and ~25nl of virus was injected.  Mice injected with the 
Ad-iN/syn-mCherry tracer were individually housed for five days following injection to 
allow for viral transduction and protein transport before perfusion, whereas mice 
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injected with modified rabies virus were perfused seven days following rabies virus 
injections.   Mice injected with AAV-Flex-hM3Dq were allowed to recover for fourteen 
days following surgery before further experiments were performed, whereas bodyweight 
and food intake analysis on mice injected with AAV-Flex-TetTox began seven days 
following surgery. 
 
Longitudinal bodyweight, food intake, and calorimetry measurements 
Mice injected with AAV-DTA, AAV-Flex-TetTox, or control viruses were allowed to 
recover for 7 days before weekly body weight and food intake measurements began.  
Two weeks after surgery, blood glucose was measured following a four-hour fast (AAV-
DTA only).  Energy expenditure was monitored using the Comprehensive Laboratory 
Monitoring System (CLAMS, Columbus Instruments) in the University of Michigan’s 
Small Animal Phenotyping Core to obtain multi-parameter analysis including open 
circuit calorimetry and activity via optical beam breaks 11 (AAV-Flex-TetTox) or 25 
(AAV-DTA) days post injection.  Mice were allowed to acclimatize to the chambers for 
two days, followed by VO2 and locomotor activity data collection for three consecutive 
days.  Body composition analysis (EchoMRI) was performed prior to CLAMS 
measurements, as well as 7 weeks following injection (AAV-Flex-TetTox only).  
 
MT-II-induced feeding suppression 
Five weeks following viral injection, IRS4-iCre mice injected with AAV-Flex-TetTox and 
appropriate controls were fasted during the light cycle (9:00-18:00).  At the onset of the 
dark cycle, mice received an i.p. injection of PBS or melanotan-II (MT-II, 150 ug/mouse, 
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Bachem) and ad libitum access to food.  Food intake was measured two and four hours 
post injection.  The following week, injections were counterbalanced and corresponding 
food intake measured.  
 
Effect of PVHIRS4 neuronal activation on feeding and energy expenditure 
Following recovery, IRS4-iCre +AAV-Flex-hM3Dq mice underwent feeding and energy 
expenditure assays as previously described.  Briefly, to measure changes in energy 
expenditure, IRS4-iCre +AAV-Flex-hM3Dq mice were acclimatized to CLAMS units for 
two consecutive days.  Importantly, energy expenditure measurements were performed 
in mice naïve to CNO, since previous results suggest CNO-induced increases in 
baseline VO2 (Chapter II).  Following acclimatization, food was removed from metabolic 
cages during the light cycle on experimental days beginning two hours prior to 
experiments.  Mice received an i.p. injection of vehicle (10% β-cyclodextrin, Sigma) and 
CLAMS measurements analyzed for the following four hours. Mice remained in the 
chambers with food access at the onset of the dark cycle and the experiment repeated 
at the same time the following day instead with i.p. injection of CNO (0.3 mg/kg in 10% 
B-cyclodextrin).  In experiments aimed to identify satiety induced by IRS4PVH neuronal 
activation, mice were fasted during the day and received an i.p. injection of vehicle at 
the onset of the dark cycle with the presentation of food.  Food intake was measured at 
two and four hours after injection and the experiment repeated the following day upon 
injection of CNO at the onset of the dark cycle.  With the exception of two mice, the 
majority of IRS4-iCre +AAV-Flex-hM3Dq mice used for CLAMS were also used for 
feeding suppression assays, and therefore feeding suppression was not performed in 
89
CNO-naïve mice.  No statistical changes were identified between the two groups in 
either baseline feeding or CNO-mediated feeding suppression (unpaired t-test, vehicle: 
p=0.71; CNO: p=0.47).  Data collected in Chapter II was used to compare AAV-Flex-
hM3Dq results to the physiologic outcomes following activation of other PVH subsets. 
 
Perfusion and Immunohistochemistry (IHC) 
At the end of all experiments, mice were perfused to verify viral injection sites.  Briefly, 
mice were deeply anesthetized with an overdose of pentobarbital (150 mg/kg, IP) and 
transcardially perfused with sterile PBS followed by 10% neutral buffered formalin or 4% 
paraformaldehyde (for perfusions with spinal cord removal).  Epididymal and perirenal 
fat pad weights were dissected and weighed following perfusion in mice injected with 
AAV-DTA or AAV-Flex-TetTox.  Brains and spinal cords (syn-mCherry injections only) 
were removed, post-fixed, and dehydrated in 30% sucrose before sectioning into 30 µm 
slices on a freezing microtome (Leica).  Coronal brain sections were collected in four 
representative sections whereas longitudinal thoracic spinal cord sections were 
collected in three representative sections and stored at -20°C.  For 2A peptide 
immunohistochemistry (IHC), free floating brain and spinal cord sections were 
pretreated with 30% H2O2 to remove endogenous peroxidase activity and then blocked 
with normal goat or donkey serum and incubated in primary antibody overnight (rabbit 
anti-2A 1:1,000, Millipore).  Detection of primary antibody was performed by avidin-
biotin/diaminobenzidine (DAB) method (Biotin-SP-conjugated Donkey Anti-Rabbit, 
Jackson Immunoresearch, 1:200; ABC kit, Vector Labs; DAB reagents, Sigma).  
mCherry and choline acetyltransferase (ChAT) were detected using with primary 
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antibodies for dsRed (rabbit 1:1000, Clontech, 632496) and ChAT (spinal cords only; 
goat, 1:500, Millipore AB144P) respectively followed by secondary immunofluorescence 
detection with donkey anti-rabbit-Alexa 568 or donkey anti-goat-Alexa 488 (1:200, 
Invitrogen).  For PVH colocalization and rabies experiments, IHC immunostaining was 
performed using primary antibodies for GFP (rabbit 1:20,000, Invitrogen A6455), nNos1 
(sheep 1:1500, (24), kindly provided by Dr. Vincent Prevot), neurophysin (goat, 1:1000, 
Santa Cruz Biotechnology, sc-7810) and copeptin (goat 1:1000, Santa Cruz 
Biotechnology, sc-7812).  For all AAV-DTA and AAV-hM3Dq injections, bilateral PVH hit 
sites were verified and misses eliminated from data analysis.  Imaging was performed 
using an Olympus BX-51 upright microscope with DP30BW camera (Olympus, Figures 
3.1B-C, 3.2, 3.4, Figure 3.2D-E, ), Nikon 90i upright microscope (Nikon) with CoolSNAP 
HQ2 CD camera (Photometrics, Figures 3.1K-N, 6), or an Olympus BX-53 upright 
microscope (Olympus) with G6000 camera (Q imaging, Figures 3.1D, 3.3, Figure 3.2B-
C, Figure 3.5-3).        
 
Statistical Analysis 
Paired t-tests, one-way ANOVAs or two-way ANOVAs followed by Tukey or Sidak’s 
post-hoc tests were calculated using GraphPad Prism 6 as appropriate.  Significance 
was determined for p<0.05.  
   
Results 
IRS4 neurons are distinct from other PVH populations 
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Recent reports indicate the necessity of IRS4 and IRS2 synergy in neurons lacking the 
leptin receptor (LepRb) in obesity prevention (25).  Since in situ hybridization results 
(Allen Brain Atlas) reveal dense Irs4 expression in the PVH, a site lacking significant 
LepRb production, we sought to determine the role of IRS4PVH neurons on energy 
homeostasis using Cre-dependent technology in combination with an IRS4-iCre mouse 
model.  The Irs4 gene is located on the X chromosome leading to random X inactivation 
of Cre activity in female mice, therefore male mice were used exclusively in all studies.  
Initial studies aimed at determining the overlap of PVH populations with IRS4PVH 
neurons using a Cre-dependent GFP reporter (lox-GFP) led to germline recombination 
and systemic GFP expression.  Therefore, Cre-activity driven by Irs4 expression was 
instead identified using injection of a Cre-dependent GFP reporter virus in the PVH of 
IRS4-iCre mice (Figure 3.1A). Of note, this approach eliminates the possibility of 
overrepresentation of the IRS4PVH population due to developmental Irs4 expression and 
more accurately aligns with the Cre-dependent viral technology used throughout this 
study.  Brains stained for GFP (indicating IRS4-iCre activity) and neurophysin I, the 
carrier protein for oxytocin, indicate that adult IRS4PVH neurons do not substantially 
overlap with OXTPVH neurons (Figure 3.1B).  Since our previous work revealed that non-
OXT Nos1PVH neurons are capable of controlling feeding, we hypothesized that IRS4PVH 
neurons might be contained within the Nos1PVH field.  Immunoreactivity for Nos1 peptide 
and GFP in IRS4-iCre mice injected with AAV-Flex-GFP demonstrates that IRS4PVH 
neurons are in fact a separate population from Nos1 as well (Figure 3.1C).  Lastly, since 
AVPPVH neurons are also able to modestly control feeding, we determined if IRS4PVH 
neurons are distinct from the AVPPVH population. Indeed, GFP-identified PVH neurons 
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representing IRS4-iCre activity do not overlap substantially with immunoreactivity for 
copeptin, the carrier molecule for AVP (Figure 3.1D).  To corroborate these results, 
mice still harboring the neo selection cassette upstream of ires-Cre were crossed to lox-
GFP mice in an attempt to eliminate the ectopic, germline GFP expression (Figure 
3.2A). Indeed, GFP expression, indicating IRS4-neo-iCre activity, is identified in the 
PVH (Figure 3.2B).  Using this approach, IRS4PVH neurons do not show significant 
overlap with OXTPVH, AVPPVH, or Nos1PVH neurons (Figure 3.2C-E, respectively). Taken 
together, these data suggest that IRS4PVH neurons represent a novel PVH 
subpopulation.  
 
IRS4PVH neurons project to hindbrain and spinal cord regions 
To determine the neural circuits engaged by IRS4PVH neurons, we identified their 
synaptic targets using PVH-directed injection of a Cre-dependent adenovirus, 
synaptophysin-mCherry (syn-mCherry), capable of highlighting neuronal synaptic 
terminals in IRS4-iCre mice.  Unilateral injection of syn-mCherry identifies robust 
IRS4PVH projections to hindbrain projection targets including the parabrachial nucleus 
(PBN), nucleus of the solitary tract (NTS), and the dorsal motor nucleus of the vagus 
(DMV) (Figure 3.3A-C).  IRS4PVH neurons also send projections to the median 
eminence, a site important for endocrine control through the pituitary (Figure 3.3D).  In 
addition to hindbrain regions, syn-mCherry projections were identified in the 
intermediolateral column (IML) of the thoracic spinal cord in close proximity to choline 
acetyltransferase (ChAT)-producing neurons, suggesting potential control of 
sympathetic activity via IRS4PVH neurons (Figure 3.3E).  Of note, these results are 
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strikingly similar to projections originating from Nos1PVH neurons, as previously shown 
(Figure 2.2F-I).   
 
Modified rabies virus identifies projection-specific regulation of IRS4PVH neurons 
Since IRS4PVH neurons are separate from Nos1PVH neurons, yet also project to 
hindbrain and spinal cord sites important for feeding and energy expenditure, we sought 
to determine the neuroanatomical regulation of IRS4PVH neurons by sites throughout the 
brain.  We hypothesized that regulation of distinct IRS4PVH circuits might differ based on 
IRS4PVH neuronal projection site, and therefore identified monosynaptic inputs to either 
NTS-projecting or PBN-projecting IRS4PVH neurons in the same brain.  We employed a 
modified rabies virus approach that requires Cre-dependent helper virus (AAV-Flex-
TVA-B19G) expression.  Due to limited efficacy with previously used helper virus 
reagents, we generated a Cre-dependent helper virus that co-expresses both the TVA 
receptor and B19 glycoprotein (B19G) using a 2A peptide linker (Figure 3.4A). Modified 
rabies virus (EnvA-ΔG-mCherry (rabies-mCherry) or EnvA-ΔG-GFP (rabies-GFP)) 
cannot enter cells without the TVA receptor; it is also modified to express a fluorescent 
protein (mCherry or GFP) instead of B19G (21, 22).  Therefore, infection of the modified 
rabies virus requires prior helper virus expression of the TVA receptor.  Furthermore, 
B19G (expressed by the helper virus) is required for retrograde transport of rabies-
mCherry or rabies-GFP (Figure 3.4B,C).  This is demonstrated by a lack of rabies-
mCherry expression in the brain of Sim1-Cre mice in which the helper virus injection 
missed the PVH (determined by a lack of 2A staining in the PVH), despite rabies-
mCherry injection into the NTS (Figure 3.5A).  With this approach, non-Cre expressing 
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neurons upstream of primary infected neurons do not have B19G, thereby identifying 
monosynaptic inputs to IRS4PVH neurons with rabies-mCherry or rabies-GFP.   
TVA receptor is expressed throughout the cell body and at synaptic terminals, 
thereby allowing terminal-specific rabies infection (26).  In order to characterize inputs to 
projection-specified IRS4PVH neurons, we performed dual rabies virus injections at 
disparate projection targets in the same mouse.  Specifically, three weeks following 
helper virus injection, rabies-mCherry was injected in the NTS whereas rabies-GFP was 
injected into the PBN.  Moderate neuronal gliosis at the site of rabies virus injection 
occurs and therefore allows for injection site verification (Figure 3.4K-L).  While IRS4PVH 
neurons that project to the NTS or PBN are largely distinct, some neuronal co-
localization between GFP and mCherry identifies neurons that regulate both the NTS 
and PBN (Figure 3.4E-G).   
With this technique, it cannot be determined whether these overlapping PVH 
populations are non-IRS4 afferents to NTS-projecting and PBN-projecting neurons, or 
whether IRS4PVH neurons send collateral projections to both targets.  To verify results, 
both versions of rabies virus (rabies-mCherry + rabies-GFP) were mixed and injected in 
the PBN of Sim1-Cre mice previously injected with helper virus in the PVH.  While PVH 
neurons co-labeled GFP and mCherry, rabies-GFP expression was markedly reduced 
in comparison to rabies-mCherry, suggesting attenuated efficacy of rabies-GFP (Figure 
3.5C-D).  Therefore, results obtained using dual-rabies virus injection in the same 
mouse likely underreport neuronal regulators of PBN-projecting IRS4PVH populations.  
Moreover, these control injections indicate that very few neurons upstream of PVH 
populations are capable of co-expressing rabies-GFP and rabies-mCherry (Figure 3.5E-
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F).  Therefore, although it appears that regulators of PBN-projecting or NTS-projecting 
IRS4PVH neurons are predominantly distinct, it is still possible that some of the same 
neuronal inputs are regulating both populations.  Nonetheless, our findings are 
consistent with previous literature evaluating PVH circuitry, demonstrating that the 
arcuate nucleus (ARC) is the main region upstream of NTS-projecting IRS4PVH neurons 
(Figure 3.4G).  Additional hypothalamic sites regulating NTS-projecting IRS4PVH 
neurons include the lateral hypothalamic area (LHA) and the dorsomedial hypothalamus 
(DMH), whereas sites upstream of PBN-projecting IRS4PVH neurons largely include the 
ventromedial hypothalamus (VMH) and LHA.  Some LHA neurons co-express GFP and 
mCherry, suggesting dual-regulation of the IRS4PVH-PBN and IRS4PVH-NTS circuits.  
Forebrain sites including the preoptic area (POA) and bed nucleus of the stria terminalis 
(BNST) include largely non-overlapping populations upstream of both IRS4PVH circuits, 
suggesting distinct forebrain circuits capable of regulating IRS4PVH neuronal function.  
Although few midbrain or hindbrain regions express rabies-mCherry or rabies-GFP, 
rabies-mCherry identifies lateral PBN neurons upstream of NTS-projecting IRS4PVH 
neurons, thereby connecting multiple PVH projection targets to one another via IRS4PVH 
neurons.    
 
IRS4PVH neurons are capable of regulating both feeding and energy expenditure 
Since IRS4PVH neuronal populations receive dense input from other hypothalamic 
regions important for relaying information regarding an organism’s energy status, we 
aimed to determine the sufficiency of these neurons in regulating distinct aspects of 
energy balance.  Thus, we used Cre-dependent DREADD (Designer Receptors 
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Exclusively Activated by Designer Drugs) viruses that enable acute modulation of 
neuronal activity using a modified G-protein coupled receptor in response to peripheral 
injection of an otherwise inert compound, clozapine N-oxide (CNO).  In this way, 
bilateral injection of the Cre-dependent Gq-coupled DREADD (AAV-Flex-hM3Dq) allows 
for remote neuronal activation in response to CNO administration (Figure 2.5).  To 
achieve remote activation of IRS4PVH neurons, we performed bilateral PVH injection of 
AAV-Flex-hM3Dq in IRS4-iCre mice (Figure 3.6A-C). Following recovery, mice were 
fasted during the day and injected with either vehicle or CNO at the onset of the dark 
cycle, when feeding normally occurs. Activation of IRS4PVH neurons results in robust 
suppression of feeding (Figure 3.6D).  In an attempt to compare the ability of the 
IRS4PVH subpopulation to regulate feeding to other PVH populations previously studied, 
the change in feeding resulting from PVH neuronal activation detailed in Chapter II 
using the same experimental parameters was grossly compared to IRS4PVH neuronal 
activation results.  Indeed, activation of IRS4PVH neurons is capable of suppressing 
feeding to a similar degree as activation of the entire PVH (using Sim1-Cre) or Nos1PVH 
neurons (Figure 3.6E).  To test the ability of IRS4PVH neurons to regulate energy 
expenditure, the same mice were placed in metabolic chambers where oxygen 
consumption (VO2) and locomotor activity were measured.  In the absence of food, 
activation of IRS4PVH neurons increases both VO2 and total activity (Figure 3.6F, H, J).  
As with feeding data, a similar comparison was performed to other PVH populations 
previously studied, suggesting that IRS4PVH neuronal activation does not increase VO2 
to the same degree as total PVH activation, even though it is likely more than that 
achieved with Nos1PVH or OXTPVH neuronal activation (Figure 3.6I). Some of these 
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changes in VO2 appear to be independent of locomotor activity, since the change in 
activity achieved by IRS4PVH neuronal activation is less than that achieved by total PVH 
activation (Figure 3.6G).             
 
IRS4PVH neurons are necessary for normal feeding and energy balance 
To test the necessity of IRS4PVH neurons for body weight regulation, we used bilateral 
injection of a Cre-dependent diphtheria toxin virus (AAV-DTA) in IRS4-iCre mice, to 
ablate neurons in adult mice (Figure 3.7A).  In comparison to control Cre-dependent 
viral injections into the PVH, mice with IRS4PVH neuronal ablation show robust obesity 
driven by hyperphagia within three weeks following viral injection (Figure 3.7B-E). This 
is demonstrated by analyzing 7 day food intake prior to the onset of significant obesity, 
from 14-21 days following injection, in which AAV-DTA injected mice eat significantly 
more than controls (Figure 3.7G).  In contrast, AAV-DTA mice did not show any 
difference in energy expenditure as measured by oxygen consumption and total X 
activity when measured days 25-28 days following injection, despite elevated lean body 
mass (Figure 3.7I-L).  Analysis of fat pad weights at the end of the study indicates that 
both epididymal and perirenal fat pad weights are increased after IRS4PVH neuronal 
ablation. Importantly, bilateral injection of AAV-DTA in the PVH of wildtype mice not 
expressing Cre recombinase does not change bodyweight or feeding (Figure 3.8A-D). 
 Although IRS4PVH neuronal ablation showed robust changes in energy balance, 
post-study immunohistochemical verification of PVH hit sites identified alteration in PVH 
architecture and decreased expression of non-IRS4PVH neuronal populations in 
comparison to control injections (Figure 3.8E, 2F).  Since AAV-DTA injections in control 
98
animals did not show any expression (data not shown), it is possible that DTA-mediated 
IRS4PVH neuronal ablation is inherently hazardous to surrounding neurons and therefore 
PVH architecture changes in response to varying degrees of PVH cell death. As this 
potentially confounds results obtained from IRS4PVH neuronal ablation, we sought to 
permanently silence IRS4PVH neurons using a Cre-dependent tetanus toxin virus (AAV-
Flex-TetTox) that cleaves the SNARE protein, synaptobrevin, and inhibits synaptic 
vesicle release (27).  This construct has been modified to express the A subunit and 
therefore does not travel retrogradely, limiting neuronal silencing to IRS4PVH neurons 
(28) (Figure 3.9A).  Similar to IRS4PVH neuronal ablation, IRS4PVH neuronal silencing in 
adult mice results in rapid hyperphagia and corresponding obesity in comparison to 
IRS4-iCre mice injected with a control virus or WT mice injected with AAV-Flex-TetTox 
(Figure 3.9B-D), with no changes in energy expenditure or body composition measured 
prior to the onset of obesity (Figure 3.9E-I).  Given the important role of the PVH in 
mediating melanocortin-induced satiety, and the identification of numerous ARC inputs 
to IRS4PVH neurons, we tested the ability of the melanocortin agonist MTII to drive 
changes in dark cycle feeding in mice without the ability to transmit information from 
IRS4PVH neurons.  Although MTII injection (150 ug/mouse) was able to suppress both 
two and four hour feeding in both control cohorts, this response was greatly diminished 
in mice with IRS4PVH neuronal silencing suggesting that IRS4PVH neuron activity is 
required for the melanocortin response (Figure 3.9J).  Post-hoc IHC analysis of IRS4-
iCre +AAV-Flex-TetTox injections is ongoing to validate PVH hit sites.  Since preliminary 
results suggest that only 1/4 IRS4-iCre mice display appropriate bilateral AAV-Flex-
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TetTox expression, additional cohorts will likely be required to further analyze the effect 
of IRS4PVH neuronal silencing.  
 
Discussion  
Recent advances in genetic mouse models used in combination with chemogenetic and 
optogenetic tools have greatly advanced our understanding of the role of the PVH in 
controlling energy balance through feeding and/or energy expenditure.  Nonetheless, 
few studies have genetically identified specific PVH populations crucial for these 
functions.  It is now well established that Mc4RPVH neurons are critical for feeding but 
seem dispensable for energy expenditure regulation (12, 13, 29, 30).  The role of other 
PVH populations in the control of feeding behavior and energy balance has not been 
well characterized.  Our previous work suggests the importance of non-OXT Nos1PVH 
population in feeding regulation (Chapter II).  Here, we identify a smaller, non-OXT, and 
non-Nos1PVH population expressing insulin receptor substrate 4 that is necessary for 
normal feeding and bodyweight maintenance.   
 While our previous studies narrowed down the PVH population capable of 
controlling feeding, it was pressing to determine if there is a unifying genetic identity for 
PVH “feeding” neurons.  We have found that multiple PVH populations (Sim1, Nos1, 
and now IRS4) are capable of coordinating feeding behavior.  Interestingly IRS4PVH 
neurons do not express Nos1 peptide, yet are both necessary and sufficient in the 
regulation of feeding and bodyweight maintenance.  To test necessity, multiple 
experimental methods were taken to achieve either ablation or silencing of IRS4PVH 
neurons, with similar resultant phenotypes.  Our initial attempt at IRS4PVH neuronal 
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ablation appears to alter PVH architecture and therefore confounds our interpretation of 
the resulting effects on energy balance parameters.  Given that the PVH is 
overwhelmingly glutamatergic, it is possible that DTA-induced IRS4PVH neuronal cell 
death results in significant glutamate release within the PVH causing local excitotoxicity 
in non-Cre (and therefore non-DTA-expressing) neurons (17, 31).   Still, preliminary 
studies suggest that permanent inhibition of IRS4PVH-specific synaptic release also 
resulted in robust obesity due to altered feeding, but not energy expenditure.  In 
contrast, chemogenetic activation using AAV-Flex-hM3Dq indicates IRS4PVH neurons 
are capable of controlling both feeding behavior and energy expenditure.  While 
changes in oxygen consumption are seemingly larger than results obtained from total 
PVH activation from previous studies, this could be partially due to non-activity induced 
changes in energy expenditure since total activity changes in response to IRS4PVH 
neuronal activation are less than that obtained when activating all PVH neurons.  
Additionally, the sufficiency of IRS4PVH neurons to change energy expenditure in an 
acute setting, despite not being necessary for normal energy expenditure, is interesting.  
A plausible explanation for this phenomenon could be the likely connection of IRS4PVH 
neurons with local PVH circuits, causing large-scale activation of other PVH neurons 
resulting in an “indirect” energy expenditure effect (15, 17).   
The circuitry used by IRS4PVH neurons to regulate feeding and energy 
expenditure are similar to those investigated for Nos1PVH neurons, since IRS4PVH 
neurons also project densely to hindbrain sites including the PBN and NTS, as well as 
sending sparse projections to the spinal cord.  While our studies do not indicate which 
projection site is relevant for controlling these distinct physiologic responses, it is likely 
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that IRS4PVH neurons projecting to the PBN control feeding behavior since the PBN is 
the relevant output in Mc4R-mediated feeding suppression (29).  Further investigation 
will be required to determine whether IRS4PVH neurons are part of this Mc4RPVH 
population that controls feeding through the PBN, or whether distinct PVH populations 
control feeding and energy expenditure via disparate projection sites (e.g. PBN vs. NTS 
vs. IML).  Although it is possible that some IRS4PVH neurons express Mc4R, it is likely 
that many do not, since IRS4PVH neurons can control energy expenditure whereas 
Mc4RPVH neurons do not (29).  Moreover, it is unclear if Mc4RPVH neurons are capable 
of suppressing feeding to the same extent as the entire PVH, suggesting the potential 
for non-Mc4R dependent control of feeding behavior by the PVH.   
 Since IRS4PVH and Nos1PVH neuronal populations are distinct and both capable 
of driving increased energy expenditure, it is not surprising that IRS4PVH neurons are 
dispensable in the control of energy expenditure.  However, whether this reflects 
redundancy in the PVH in energy expenditure regulation is unknown.  It is certainly 
possible that non-IRS4PVH neuronal populations (i.e. Nos1) are necessary for energy 
expenditure control, despite the ability for IRS4PVH neurons to drive energy expenditure 
changes.  Certainly, this is the case for PVH circuits driving satiety since the necessity 
of IRS4PVH neurons in the control of feeding indicate that the Nos1PVH circuit requires 
additional PVH populations to achieve feeding suppression upon chemogenetic 
activation.  This finding raises the possibility that PVH interconnectivity is functionally 
relevant in feeding control, and potentially energy expenditure.  Certainly, connections 
between separate PVH populations are well documented (17, 32-34).  Moreover, 
monosynaptic retrograde tracing from hindbrain-projecting IRS4PVH neurons suggest 
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dense PVH interconnectivity; this finding suggests that PVH populations have the 
potential to function as a large unit and coordinately regulate hindbrain structures. 
 The PVH has been well documented as a hypothalamic relay station, situated to 
receive dense innervation from sites critical for feeding and energy expenditure 
regulation and transmit this information to hindbrain sites to achieve corresponding 
physiologic and behavioral responses (5, 35-37).  Yet, studies to date have not been 
able to piece together multiple components engaging projection-specific PVH circuits.  
Here, we identify unique regulators of NTS-projecting and PBN-projecting IRS4PVH 
neurons.  We demonstrate that NTS-projecting IRS4PVH neurons receive dense 
innervation from the ARC, confirming this approach in a well-defined circuit.  Moreover, 
the relevance of this circuit is illustrated by the inability of melanocortin agonists to 
reduce feeding in mice in which IRS4PVH neurons have been silenced. Although these 
studies were unable to fully characterize ARC inputs to IRS4PVH populations due to 
technical limitations, it is possible that POMCARC neurons are directly upstream of the 
IRS4PVH population.  Additionally, PBN-projecting IRS4PVH neurons receive innervation 
from the VMH.  Given the role for direct PVH connections to the PBN in mediating 
Mc4R-induced satiety, it is possible that the VMH-IRS4PVH-PBN circuit is relevant in 
feeding control, though future studies will be necessary to determine this (29).  Results 
obtained from retrograde tracing indicate that inputs to IRS4PVH neurons projecting to 
the hindbrain are largely hypothalamic, further validating the role for the PVH as a 
hypothalamic relay station.  
 Taken together, our results demonstrate that IRS4PVH neurons are a unique 
population capable of controlling feeding behavior and overall energy balance, 
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presumably through projections to hindbrain and spinal cord regions.  Moreover, 
synaptic release from PVH neurons containing IRS4 is essential in preventing 
hyperphagia and obesity.  Furthermore, we identify the potential for an interconnected 
PVH in the regulation of hindbrain structures previously shown to control energy 
balance parameters.  While the significance of this communication between PVH 
subpopulations in the control of distinct aspects of energy balance remains to be 
elucidated, it is apparent that further characterization of the composition and circuitry of 
individual PVH populations is necessary to fully understand the control of feeding and 
energy expenditure by an essential hypothalamic output center. 
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Figure 3.1. IRS4 neurons comprise a unique PVH population.  A) Adult IRS4-iCre 
mice were stereotaxically injected with a Cre-dependent GFP reporter virus (AAV-Flex-
GFP) in the PVH to visualize Cre-expressing neurons in the adult mouse.  B) 
Immunohistochemistry (IHC) in the PVH demonstrates limited co-localization between 
IRS4PVH neurons (green) and oxytocin (OXT, red) neurons (identified with the OXT 
carrier molecule, neurophysin).  C-D) IHC for GFP (green) and Nos1 (C, red) or 
copeptin (D, red) indicates that few IRS4PVH neurons overlap with Nos1 or AVP neurons 
in the PVH.  Dashed boxes indicate regions that are digitally enlarged and shown as 
insets.  White arrowheads indicate the few overlapping IRS4PVH neurons with respective 
PVH populations.  3V=third ventricle.   
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Figure 3.2. Cre-dependent GFP reporter mice allow for further characterization of 
IRS4PVH neurons.  A) IRS4-iCre mice still expressing the neo selection cassette (IRS4-
neo-iCre) were used to avoid systemic GFP expression resulting from germline 
recombination of Cre-dependent reporter alleles during development.  Upon crossing to 
the Cre-dependent lox-GFP mouse line, IRS4neoPVH neurons can be visualized in the 
PVH (B).  C-E) IHC for neurophysin (C), copeptin (D), and Nos1 (E), demonstrates little 
overlap between IRS4neoPVH neurons and OXT, AVP, or Nos1 respectively.  3V=third 
ventricle. 
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Figure 3.3. IRS4PVH neurons send direct projections to hindbrain and spinal cord 
regions. A) A Cre-dependent synaptophysin-mCherry adenovirus (syn-mCherry) was 
unilaterally injected in the PVH of IRS4-iCre mice to trace synaptic terminals throughout 
the brain.  B-C) IHC identification of syn-mCherry terminals is observed in hindbrain 
regions including the medial and lateral parabrachial nucleus (mPBN, lPBN, 
respectively, B), as well as the dorsal motor nucleus of the vagus (DMV) and nucleus of 
the solitary tract (NTS, C).  D) IRS4PVH neurons also project to the median eminence 
(ME).  E) Syn-mCherry (red) identifies synaptic terminals in the intermediolateral column 
of the spinal cord (IML) in close proximity to neurons expressing choline 
acetyltransferase (ChAT, green).  scp= superior cerebellar peduncle, 4V=fourth 
ventricle, 3V=third ventricle, AP=area postrema          																								
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Figure 3.4. Identification of monosynaptic inputs to NTS-projecting or PBN-
projecting IRS4PVH neurons using modified rabies virus.  A) A Cre-dependent helper 
virus construct is used to insert rabies B19 glycoprotein (B19G) and the TVA receptor 
(blue receptor, D) in IRS4PVH cell bodies and terminals.  Modified rabies virus expresses 
a fluorescent tag (mCherry, B; GFP, C) instead of B19G.  After initial infection with 
helper virus, rabies-mCherry is injected at one projection site (NTS), whereas rabies-
GFP is injected at another (PBN) in the same mouse.  E-G) IHC for mCherry and GFP 
identify largely non-overlapping NTS-projecting and PBN-projecting IRS4PVH neurons, 
respectively.  Sites upstream of both NTS and PBN-projecting IRS4PVH neurons include 
the supraoptic nucleus (SON), amygdala (H), bed nucleus of the stria terminalis (BNST, 
I), preoptic area (POA, I), and lateral hypothalamic area (LHA, J).  The ventromedial 
hypothalamus (VMH) is upstream of PBN-projecting IRS4PVH neurons (JII, green), 
whereas both the arcuate nucleus (ARC, JII, red) and PBN (K, red) are upstream of 
IRS4PVH neurons projecting to the NTS.  Glial damage represents injection site in the 
PBN (K, green) and NTS (L, red).  3V=third ventricle, oc=optic chiasm, MeA=medial 
amygdala, BMA=basomedial amygdala, vBNST=ventral BNST, vlPOA=ventral lateral 
POA, MPOA=medial POA, MnPO=median preoptic nucleus, aca=anterior part of 
anterior commissure, DMH=dorsomedial hypothalamus, aq=aqueduct, 4V=fourth 
ventricle 								
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Figure 3.5.  Dual rabies virus infection is limited in efficacy.  A) IHC in the PVH of 
Sim1-Cre +AAV-Flex-TVA-B19G mice validates a “miss” since 2A staining is not 
detected. Still, NTS-directed rabies-mCherry injection in the same mouse displays 
limited mCherry expression in the PVH, therefore confirming the requirement of AAV-
Flex-TVA-B19G expression for modified rabies virus expression.  B) 2A expression in 
wildtype mice injected with AAV-Flex-TVA-B19G demonstrates that Cre recombinase is 
required for helper virus expression.  C) Injection of both rabies-mCherry and rabies-
GFP in the same PBN projection target in Sim1-Cre +AAV-Flex-TVA-B19G mice 
illustrates that both rabies viruses can be expressed in PBN-projecting PVH neurons 
(D), though sites upstream including the bed nucleus of the stria terminalis (BNST, E), 
preoptic area (POA), arcuate nucleus (ARC, F) and VMH (F) show limited co-labeling.  
G) Gliosis in the PBN due to rabies-mCherry/rabies-GFP injection demonstrates that 
both rabies-GFP and rabies-mCherry were mixed and injected at the same site.  
Dashed boxes indicate regions that are digitally enlarged and shown as insets.  White 
arrowheads indicate co-localization in neurons with both rabies-GFP and rabies-
mCherry.  3V=third ventricle, aca= anterior part of anterior commissure, 
DMH=dorsomedial hypothalamus, oc=optic chiasm, LHA=lateral hypothalamic area.       											
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Figure 3.6.  Acute activation of IRS4PVH neurons decreases feeding and increases 
energy expenditure.  A-C) IHC for mCherry identifies AAV-hM3Dq expression in 
IRS4PVH neurons throughout the PVH (yellow dotted line).  D) Two-hour food intake was 
decreased at the onset of dark cycle feeding due to activation of IRS4PVH neurons 
following an i.p. injection of CNO in comparison to vehicle.  E) CNO-induced two-hour 
feeding suppression was compared across different PVH cell types (WT, Sim1, Nos1 
and OXT data obtained from chapter II), suggesting the possibility that food suppression 
driven by IRS4PVH neuronal activation is comparable to suppression obtained from 
activating the entire PVH with Sim1PVH neurons.  F) Activation of IRS4PVH neurons 
increases total activity and oxygen consumption (H, J) over a four-hour time period in 
the absence of food.  I) Similar comparisons to previously studied PVH populations 
suggests that IRS4PVH neuronal activation potentially increases oxygen consumption 
more than that obtained upon Nos1PVH or OXTPVH neuronal activation, without changing 
total activity to the same degree as Sim1PVH neurons (G).  Average values ± SEM are 
shown, **p<0.01, ***p<0.001, compared to vehicle values.  AH=anterior hypothalamus, 
SCN=suprachiasmatic nucleus, PVH=paraventricular nucleus of the hypothalamus															
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Figure 3.7.  IRS4PVH neurons are necessary for normal feeding and bodyweight.  
A) A Cre-dependent adeno-associated virus expresses diphtheria toxin A exclusively in 
Cre-expressing neurons, resulting in Cre-dependent neuronal ablation.  B, C) IRS4PVH 
neuronal ablation in IRS4-iCre +AAV-DTA mice results in increased bodyweight in 
comparison to IRS4-iCre mice injected with a control AAV.  D) IRS4-iCre mice show 
increased cumulative food intake following IRS4PVH neuronal ablation in comparison to 
controls.  E) IRS4-iCre littermate mice injected with either AAV-control (left) or AAV-
DTA (right) at 9 weeks post-injection demonstrate the profound obesity resulting from 
IRS4PVH neuronal ablation, with corresponding increases in epididymal and perirenal fat 
pad weights (F).  G) Prior to the onset of significant obesity (days 14-21), cumulative 7-
day food intake (G) and fasted blood glucose (H) was higher in IRS4-iCre +AAV-DTA 
mice in comparison to controls.  I-L) Oxygen consumption and total X activity was 
unchanged due to IRS4PVH neuronal ablation (I, J, L) measured 25-28 days post-
injection, while lean body mass was slightly increased in IRS4-iCre +AAV-DTA mice (K).  
Average values ± SEM are shown, **p<0.01, ***p<0.001, ****p<0.0001 compared to 
AAV-control values  (DTA: B-C n=5; D n=4; F, I-L n=3; G n=5; AAV-control: B-D, G n=9; 
F, H n=8; I-L n=7).  Significance was measured using a two-way ANOVA followed by 
Sidak’s multiple comparisons test if necessary (B-D, I, K, L) or an unpaired t-test (F-H, 
K). 				
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Figure 3.8.  PVH-directed injection of AAV-DTA virus in wildtype (WT) mice does 
not cause obesity.  A-C) WT mice injected with the Cre-dependent AAV-DTA virus 
(green) do not show changes in bodyweight or food intake (C) in comparison to IRS4-
iCre +AAV-DTA mice (red).  D) 7-day food intake is not elevated in WT mice injected 
with AAV-DTA during 14-21 days post-injection.  E) IHC in IRS4-iCre mice injected with 
a Cre-dependent control virus expresses hrGFP in IRS4PVH cells (green) and 
demonstrates appropriate expression of non-IRS4PVH cells including oxytocin (OXT, red) 
and copeptin (blue).  F) In contrast, IHC in brains from IRS4-iCre +AAV-DTA mice 
display altered PVH architecture with an enlarged third ventricle (3V) and decreased 
expression of OXT (green) and copeptin (blue).  Average values ± SEM are shown, 
*p<0.05, **p<0.01, ***p<0.001  (IRS4-iCre: A-B,D n=5, C n=4; WT n=3).  Significance 
was measured using a paired t-test (D, F, H, J) or a two-way ANOVA followed by 
Sidak’s multiple comparisons test (A-C) or an unpaired t-test (D).     																					
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Figure 3.9.  IRS4PVH neuronal silencing results in hyperphagic obesity.  A) A Cre-
dependent tetanus toxin virus (AAV-Flex-TetTox) causes inhibition of synaptic 
exocytosis in Cre-expressing cells.  B-D) IRS4PVH neuronal silencing results in robust 
obesity due to increased cumulative food intake in comparison to nontransgenic mice 
injected with AAV-Flex-TetTox (NT +AAV-Flex-TetTox) or IRS4-iCre mice injected with 
a control AAV-Flex-GFP virus.  E-I) No changes are observed in IRS4-iCre +AAV-Flex-
TetTox mice in comparison to controls in energy expenditure measurements including 
oxygen consumption, total X activity, or body composition measured 11 or 51 (body 
composition only) days after injection.  J) While two and four hour dark-cycle food intake 
is decreased in response to i.p. injection of the melanocortin receptor agonist melanotan 
II (MTII, 150 ug/mouse) in control mice, this response is diminished in IRS4-iCre +AAV-
Flex-TetTox mice.  Average values ± SEM are shown, **p<0.01, ***p<0.001, 
****p<0.0001 (IRS4-iCre +AAV-Flex-TetTox D-I: n=4, J-L: n=3; NT +AAV-Flex-TetTox 
D-I: n=4, J-L:n=3; IRS4-iCre +Flex-GFP D-K: n=3, L: n=2).  Significance was 
determined using a two-way ANOVA followed by Sidak’s multiple comparisons test if 
necessary.            		
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Chapter IV 
Circuit analysis of defined PVH cell-types 
 
Introduction 
Neuronal networks in the central nervous system (CNS) have evolved to carry out 
complex behavioral responses in changing environments to achieve homeostasis and 
survival.  A critical component of an organism’s homeostasis is the ability to balance 
energy intake with energy expenditure.  Although significant progress has been made in 
understanding the composition of neuronal subpopulations important in energy balance, 
interrogation of the circuits used by these neurons to communicate and ultimately 
control energy balance parameters largely remains undetermined.  Indeed, GWAS 
studies have implicated the importance of CNS circuits in body weight regulation, since 
genetic loci controlling synaptic function are disproportionately associated with 
measures of body mass (1).  This suggests the possibility that CNS circuits that were 
not evolutionarily designed in the presence of energy excess are currently under 
unusual pressure.  Since recent societal changes in feeding behavior and energy 
expenditure (and therefore, arguably, not genetics) have resulted in a dramatic increase 
in the obesity prevalence, it is pressing to understand the basic neuroanatomy of the 
CNS circuits primarily controlling negative energy balance.      
 The paraventricular nucleus of the hypothalamus (PVH) is the primary 
hypothalamic output controlling both energy expenditure and feeding (2, 3). 
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PVH-regulated feeding is in large part driven by inputs from the arcuate nucleus of the 
hypothalamus (ARC), including the ARC populations producing either agouti related 
peptide (AgRP) or proopiomelanocortin (POMC) (4-6).  AgRP neurons drive feeding 
behavior through release of the Mc4R-antagonist AgRP at projection sites (7-10).  On 
the other hand, anorexigenic POMC neurons produce and release melanocortins, 
including α-MSH, that bind melanocortin 4 receptors (Mc4R) in downstream target 
neurons (11, 12).  Mc4R-expressing neurons in the PVH are the one of the main 
downstream effectors mediating melanocortin-induced satiety (13-15).  While the ARC-
PVH circuit is the most appreciated in the hypothalamic control of feeding behavior, 
projections from numerous other hypothalamic sites that sense and control energy 
status converge on the PVH.  These sites include the lateral hypothalamic area (LHA), 
the ventromedial hypothalamus (VMH), and the dorsomedial hypothalamus (DMH) (16).  
The PVH integrates these afferent signals and suppresses feeding through projections 
to hindbrain regions that sense gastrointestinal-derived hormonal signals and neural 
signals arising from mechanical stretching of the gut (2, 17).  Specifically, the hindbrain 
sites receiving dense PVH innervation include the parabrachial nucleus (PBN), nucleus 
of the solitary tract (NTS), area postrema (AP) and dorsal motor nucleus of the vagus 
(DMV) (18-20).  Moreover, studies have also identified PVH projections to thoracic 
spinal cord regions, specifically in the intermediolateral column (IML), suggesting a 
PVH-IML circuit that may control sympathetic outflow and therefore energy expenditure 
(Chapter II, Chapter III) (19, 20).   
For over a century, neuroanatomical approaches have been used to determine 
CNS connectivity with the assumption that connections between CNS sites provide 
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information about the function of different neuronal populations.  Recent technical 
advances have made it possible to map complex circuits involving genetically-identified 
populations using modified rabies virus techniques in combination with mouse models 
expressing Cre recombinase in defined cell populations (21, 22).  Here, we use 
modified rabies virus approaches to identify and characterize monosynaptic inputs to 
genetically-defined PVH subpopulations in order to delineate a PVH circuit that 
regulates feeding and energy expenditure.  To this end, we combine projection-specific 
modified rabies virus injections in multiple Cre-expressing mouse models to identify 
inputs to PBN-projecting, NTS-projecting, or IML-projecting PVH subsets.  We find that 
PVH cell groups are highly interconnected; populations expressing neuronal nitric oxide 
synthase 1 (Nos1) and oxytocin (OXT) both receive dense innervation from other PVH 
neurons, thereby raising the possibility that parvocellular PVH subsets that project to 
disparate hindbrain and spinal cord sites are likely functioning as an interconnected 
PVH network to achieve negative energy balance.  
 
Materials and Methods 
 
Experimental Animals 
 
Sim1-Cre, Nos1-iCre, and OXT-iCre mice were generated as previously described (14, 
23, 24)).  Adult male mice (8-12 weeks old) were used for all studies. OXT-iCre mice 
that were bred to a Cre-dependent TdTomato reporter line (Ai9, Jackson Labs, 007909) 
were used to fluorescently label Cre-expressing OXT neurons.  All animals were bred 
and housed within our colony according to guidelines approved by the University of 
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Michigan Committee on the Care and Use of Animals.  All mice were provided ad 
libitum access to food and water and single housed after stereotaxic injection. 
 
Viral preparations  
A modified AAV-Flex-TVA-B19G construct was generated due to limited efficacy with 
previously used helper virus reagents.  Specifically, limited rabies virus transduction 
was observed following co-injection of commercially available AAV-Flex-TVA-mCherry 
and AAV-Flex-B19G viruses, suggesting that co-infection of both helper viruses in a 
single cell may be inefficient.  Furthermore, the previously generated AAV-Flex-TVA-
B19G-GFP construct displayed both weak GFP expression and poor rabies virus 
efficiency, possibly due to packaging such a large construct into an AAV (25).  To 
remedy this, TVA-B19G was PCR amplified from the pAAV-EF1-TVA-B19G-GFP 
plasmid (Addgene #26197) and subcloned into a TOPO cloning vector.  SpeI and SacI 
restriction sites were then used to insert the product into the pAAV-hSyn-Flex vector.  
EnvA-ΔG-mCherry (rabies-mCherry), and EnvA-ΔG-GFP (rabies-GFP) were generated 
as previously described (Chapter III) (21).  
 
Stereotaxic injections 
Stereotaxic injections were performed in Sim1-Cre, Nos1-iCre, and OXT-iCre mice as 
previously described (Chapter II).  Briefly, mice were placed in a digital stereotaxic 
frame (Model 1900, Kopf Instruments) under isofluorane and provided with pre-surgical 
analgesia. Viral injections were performed using a pressurized picospritzer system 
coupled to a pulled glass micropipette.  For all experiments (excluding those using 
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cannulas), 40-50 nl of AAV-Flex-TVA-B19G was unilaterally injected in the PVH 
(coordinates from bregma: A/P= -.500, M/L= +/- .220, D/V= -4.800).  Following three 
weeks recovery, rabies-mCherry and rabies-GFP were injected in projection sites 
including the PBN (100 nl, A/P= A/P=-4.770, M/L=+/- 1.35, D/V=-2.8), NTS, and IML.  
NTS injections were performed as previously described, whereby the fourth ventricle 
was identified and used as a geographic landmark to determine the site of injection 
(Chapter II).  A glass micropipette was lowered into the site (D/V: -.550) and 50 nl of 
virus was injected.  For injections into the IML, mice were placed in the stereotaxic 
frame without ear bars.  Instead, ear bars were used to raise and stabilize the spinal 
cord at the level of ~T2-T6.  Incisions were made through muscle layers to reveal 
vertebrae and spinal cord, and muscle held back using micro hemostatic forceps. T3-T4 
was identified using the T2 vertebral spine and T3/T4 intervertebral disks and the glass 
pipette was lowered in between T3-T4 towards the midline of the spinal cord (D/V=-
.600), where 100 nl of rabies-mCherry virus was injected.  Two minutes after the 
injection was completed, the glass pipette was raised and sutures used to close the 
wound.  Ipsilateral PBN and NTS modified rabies virus injections were performed in 
relation to helper virus injection, whereas IML injections were performed on the 
contralateral side due to neuronal decussation.   
For studies in which rabies-mCherry was injected into the PVH, cannulas were 
used to ensure identical PVH hit sites for both viral injections (AAV-Flex-TVA-B19G and 
rabies-mCherry).  For these experiments, Sim1-Cre or OXT-iCre mice were placed in 
the stereotaxic frame and the skull drilled at the same PVH coordinates used throughout 
other experiments.  A 4.3mm long guide cannula (Plastics One) was lowered into the 
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brain and secured using dental cement.  Once dental cement had hardened and the 
cannula was secure (~5 minutes), 200nl of AAV-Flex-TVA-B19G was administered 
using a Hamilton syringe coupled to tubing and an internal cannula with a 0.5mm 
overhang (total length=4.8mm).  Two minutes following helper virus injection, the 
internal cannula was removed and a dummy cannula placed in the guide cannula for 
recovery.  Following a three week recovery, dummy cannulas were removed and 75-
200 nl of rabies-mCherry injected into the PVH using an internal cannula.  Two minutes 
after virus injection, the internal cannula was removed and dummy cannula replaced 
until perfusion.  For visualization of CRFPVH neurons, colchichine (10 ug, 40 ug/ul) was 
administered directly to the PVH through the same cannula 36 hours prior to perfusion.  
Cannula hit sites were histologically verified at the completion of the experiment.                    
 
Perfusion and immunohistochemistry (IHC) 
For all studies, mice were perfused 7 days following rabies virus injection as previously 
described to verify viral hit sites for both AAV-Flex-TVA-B19G and rabies-
mCherry/rabies-GFP.  Briefly, mice were deeply anesthetized with an overdose of 
pentobarbital (150 mg/kg, IP) and transcardially perfused with PBS followed by 10% 
neutral buffered formalin.  Brains and spinal cords (for IML injections only) were 
removed, post-fixed, and dehydrated in 30% sucrose before sectioning into 30 µm 
slices on a freezing microtome (Leica).  Coronal brain sections were collected in four 
representative sections whereas longitudinal thoracic spinal cord sections were 
collected in three representative sections and stored at -20°C.  IHC for 2A peptide was 
performed to validate appropriate helper virus hit site (data not shown).  In the event 
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that helper virus missed the PVH, data was excluded.  mCherry and GFP were detected 
using with primary antibodies for dsRed (rabbit 1:1000, Clontech, 632496) and GFP 
(chicken 1:1000, Abcam, ab12970) respectively followed by secondary 
immunofluorescence (IF) detection with donkey anti-rabbit-Alexa 568 and donkey goat 
anti-chicken-Alexa 488 (1:200, Invitrogen).  For colocalization experiments between 
rabies-mCherry and ARC POMC neurons, IHC immunostaining was performed using 
primary antibodies for ACTH (rabbit 1:1000, kindly provided by Dr. Malcolm Low, Parlow 
AFP-173P) and RFP (rat, 1:1000, Allele Biotechnology ACT-CM-MRRFP10), followed 
by secondary IF detection with donkey anti-rabbit-Alexa 488 and donkey anti-rat-Alexa 
594 (1:200, Invitrogen).  In experiments aimed at identifying PVH and SON populations 
upstream of OXTPVH neurons, IHC was performed for RFP, OXT (rabbit, 1:1500, 
Bachem, T-4084), copeptin (goat 1:1000, Santa Cruz Biotechnology, sc-7812), 
neurophysin (goat, 1:1000, Santa Cruz Biotechnology, sc-7810), and CRF (rabbit, 
1:1000, Bachem, T-4037) followed by corresponding secondary antibodies (donkey 
anti-rat-Alexa 594, donkey anti-goat-Alexa 350, and donkey anti-rabbit-Alexa 488 (all 
1:200, Invitrogen)).  Imaging was performed using an Olympus BX-51 upright 
microscope with DP30BW camera (Olympus, Figures 4.1C-J, 4.6D, 4.7), Nikon 90i 
upright microscope (Nikon) with CoolSNAP HQ2 CD camera (Photometrics, Figures 
4.1K-N, 4.6), or an Olympus BX-53 upright microscope (Olympus) with G6000 camera 
(Q imaging, Figures 4.2-5).        
 
Results 
 
Modified rabies virus identifies inputs to Sim1PVH neurons 
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Using a variety of non cell-type specific retrograde viral tracing reagents, previous 
reports suggest broad inputs to the PVH from hypothalamic structures including the 
ARC, DMH, and LHA, as well as both forebrain (POA, BNST) and hindbrain (NTS, 
RVLM) sites (16, 26-31).  In order to validate the viral technologies modified for this 
study, we aimed to map neuronal inputs to all PVH neurons using the Sim1-Cre mouse 
model in combination with modified rabies virus reagents.  To this end, a Cre-dependent 
“helper virus” (AAV-Flex-TVA-B19G, Figure 4.1A) was injected in the PVH of Sim1-Cre 
mice to express both the TVA receptor and the B19 glycoprotein (B19G) in all PVH 
neurons.  Three weeks following helper virus injection, modified rabies virus (rabies-
mCherry) was injected in the PVH.  Since the TVA receptor is required for modified 
rabies virus infection, rabies-mCherry expression is dependent on prior helper virus 
expression (Chapter III, Figure 3.5).  Moreover, rabies-mCherry has been generated 
with mCherry expression instead of the native B19G, therefore requiring B19G 
expression from the helper virus for retrograde transmission (Figure 4.1B).  Importantly, 
since helper virus injection is limited to the PVH, neurons upstream do not express 
B19G unless they: 1) are within the injection site and 2) produce Cre recombinase (21).  
Therefore, this approach allows for visualization of rabies-mCherry labeled 
monosynaptic inputs to Sim1PVH neurons.  Indeed, rabies-mCherry expression is 
identified throughout the PVH, thereby tagging primary-infected PVH neurons (Figure 
4.1C, 1D).  Additionally, neurons of the supraoptic nucleus, classically thought to be 
entirely magnocellular, are labeled by rabies-mCherry, therefore identifying a direct 
SON-PVH circuit.  Rabies-mCherry also identifies BNST and POA inputs to the PVH 
(Figure 4.1E, 1F), validating previous reports (28).  Importantly, the well-defined ARC-
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PVH circuit is also identified using this approach, since rabies-mCherry is expressed 
widely throughout the ARC (Figure 4.1G-J) (4).  Additional hypothalamic structures 
innervating the PVH include the VMH, DMH, and LHA (Figure 4.1G-J).  Lastly, to 
confirm the identity of the ARC neurons synaptically connected to the PVH, we 
performed IHC for adrenocorticotropic hormone (ACTH), a cleavage product of POMC.  
Indeed, rabies-mCherry colocalizes with some ACTH cells throughout the ARC, further 
confirming the specificity of the modified rabies virus technology in a classically defined 
circuit (Figure 4.1K-N).                 
 
Terminal-restricted modified rabies virus injection identifies projection-specific circuits 
engaging the PVH 
We hypothesized that PVH projection targets represent different subsets of PVH 
populations, and that afferent inputs to these populations will therefore be distinct.  If so, 
this would imply divergent circuit control of different PVH outputs and therefore 
potentially identify regulators of distinct aspects of energy balance (feeding vs. energy 
expenditure).  In order to determine this, we performed helper virus injection in the PVH 
of Sim1-Cre mice as before.  Rather than re-injecting rabies virus injection in the PVH, 
rabies-mCherry was delivered to the NTS, a known projection target of the PVH.  In the 
same mouse, a similar modified rabies virus expressing GFP (rabies-GFP) was injected 
in the PBN (Figure 4.2A).  Since the TVA receptor can be expressed throughout axons 
and on terminals, both rabies-mCherry and rabies-GFP can infect Sim1PVH cells 
projecting to the NTS or PBN, respectively (30) (Chapter III).  Using this method, 
Sim1PVH cells expressing rabies-GFP and rabies-mCherry are largely distinct (Figure 
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4.2B-2D).  Since Nos1PVH neurons comprise some, but not all (e.g. not including 
IRS4PVH), of the PVH projections to hindbrain and spinal cord regions, we aimed to 
identify if some inputs to projection-specific Nos1PVH neurons were less than that 
observed with analysis of the entire PVH.  Thus, the same experiment was performed in 
Nos1-iCre mice, with helper virus injection in the PVH (Nos1-iCre +AAV-Flex-TVA-
B19G) followed by modified rabies virus injection in the PBN (rabies-GFP) or NTS 
(rabies-mCherry).  Similarly, Nos1PVH populations projecting to the NTS or PBN are 
largely non-overlapping since rabies-mCherry and rabies-GFP cells have minimal 
colocalization throughout the PVH (Figure 4.2E-G).  Importantly, previous results 
indicate that both rabies-mCherry and rabies-GFP can enter and express in the same 
PVH cell, strongly suggesting that PVH circuits engaging the PBN or NTS are distinct 
with limited axonal collateralization (Chapter III, Figure 3.5).  Since B19G is expressed 
in these PVH cells, rabies-mCherry and rabies-GFP can travel to neurons upstream and 
therefore identify monosynaptic inputs to NTS-projecting or PBN-projection PVH cells 
with rabies-mCherry or rabies-GFP visualization, respectively (Figure 4.3A).  
Surprisingly, inputs to NTS-projecting and PBN-projecting Sim1PVH neurons are in 
similar nuclei, yet are different neuronal populations.  Large numbers of rabies-mCherry 
and rabies-GFP cells are found in the BNST and POA (Figure 4.3B) as well as the SON 
(Figure 4.3D).  Hypothalamic areas with neurons upstream of NTS-projecting PVH 
neurons include the ARC and DMH, in addition to fewer neurons in the VMH and LHA 
(Figure 4.3F).  Rabies-GFP identifies inputs to PBN-projecting PVH neurons including 
the VMH, DMH, and some ARC neurons.  Rabies-mCherry and rabies-GFP cells are 
also located, albeit in much smaller numbers, in midbrain regions including the 
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periaqueductal gray (PAG) and zona incerta (ZI) (Figure 4.3H).  Injection sites can be 
visualized due to neuronal gliosis at the site of injection for rabies-GFP in the PBN 
(Figure 4.3J) and rabies-mCherry in the NTS (Figure 4.3L).  Additionally, rabies-
mCherry cells are expressed in the PBN, suggesting a PBN-PVH-NTS circuit (Figure 
4.3J).  In comparison to the regulation of the entire PVH, inputs to NTS-projecting or 
PBN-projecting Nos1PVH neurons are outstandingly similar.  Gross analysis of sites 
upstream of the smaller Nos1PVH population indicates that inputs to projection-defined 
Nos1PVH populations are largely the same, but rabies-GFP and rabies-mCherry show 
little colocalization (Figure 4.3C, E, G, I, K, M).       
 
Projection-specific modified rabies virus approach reveals strikingly similar circuits 
engaging distinct PVH populations  
While results obtained from dual rabies virus injection in disparate projection sites 
identified distinct circuits regulating PVH populations, rabies-GFP routinely identified 
fewer neurons than rabies-mCherry.  Although previous control results demonstrated 
that rabies-GFP and rabies-mCherry are capable of co-labeling PVH neurons, few 
populations upstream co-labeled rabies-mCherry and rabies-GFP (Chapter III, Figure 
3.5).  This highlights the possibility of different viral efficiencies between preparations of 
rabies-mCherry and rabies-GFP, with underreporting of neural populations labeled with 
GFP.  For this reason, rabies-mCherry alone was injected in Sim1-Cre +AAV-Flex-TVA-
B19G mice in different projection sites and results compared (Figure 4.4A-C).  
Surprisingly, extensive rabies-mCherry expression is observed in the PVH, appearing to 
label almost all PVH neurons, despite different rabies-mCherry injection sites  (Figure 
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4.4G-I).  Additionally, rabies-mCherry identifies similar populations upstream of Sim1PVH 
neurons projecting to the NTS, PBN, or IML.  Dense rabies-mCherry neuronal labeling 
is identified in the BNST and POA throughout all groups (Figure 4.4D-F).  
Correspondingly, hypothalamic sites including the SON (Figure 4.4G-I), ARC, DMH, and 
VMH are all upstream of NTS-projecting, PBN-projecting, and IML-projecting Sim1PVH 
neurons (Figure 4.4J-L).  While rabies-mCherry identifies that the PBN is upstream of 
NTS-projecting and IML-projecting neurons (Figure 4.4M-O), few NTS neurons express 
rabies-mCherry (Figure 4.4P-R).   
 Since Sim1PVH neurons comprise the entire PVH, we sought to characterize 
inputs to Nos1PVH neurons, a smaller population still capable of controlling both feeding 
and energy expenditure.  Thus, rabies-mCherry injection was performed in the NTS, 
PBN, or IML of Nos1-iCre +AAV-Flex-TVA-B19G mice (Figure 4.5A-C).  Sites 
throughout the CNS were largely similar to Sim1PVH results, with BNST and POA 
forebrain regions upstream of all Nos1PVH populations (Figure 4.5D-F).  Once again, 
rabies-mCherry expression in the PVH seemingly marked almost all PVH neurons, in 
addition to the SON (Figure 4.5G-I).  Hypothalamic regulation of Nos1PVH populations 
originates from the same sites as when studying the entire PVH, with rabies-mCherry 
expression in the ARC, DMH, LHA and VMH (Figure 4.5J-L).  While the PBN is 
upstream of NTS-projecting Nos1PVH neurons, rabies-mCherry is not identified in the 
PBN of Nos1-iCre +AAV-Flex-TVA-B19G mice injected with rabies-mCherry in the IML, 
suggesting a potential disparity between hindbrain inputs to IML-projecting Nos1PVH 
neurons from the entire IML-projecting Sim1PVH neuronal population (Figure 4.5M-O).  
While neuronal gliosis identifies the rabies-mCherry injection site in experiments aimed 
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to label Nos1PVH inputs to the NTS, few rabies-mCherry neurons are identified upstream 
of projection-specific PVH neurons (Figure 4.5P-R). 
 
Monosynaptic inputs to OXTPVH neurons arise primarily from other PVH neuronal 
populations 
As noted previously, communication among Cre+ PVH populations can confound 
results, highlighting the problem of using modified rabies virus techniques in sites with 
local, intranuclear connections in combination with densely expressed, and therefore 
less distinct, neuronal populations.  Therefore, we hypothesized that further limiting the 
PVH population under investigation could simplify the circuitry of PVH populations and 
better highlight inputs to defined PVH subpopulations.  Thus, we aimed to characterize 
neuronal inputs to OXTPVH neurons, a small subset of the Nos1PVH field.  Therefore, we 
performed helper virus injection in the PVH of OXT-iCre mice (OXT-iCre +AAV-TVA-
B19G), followed by rabies-mCherry injection in the same site three weeks later (Figure 
4.6A).  Rabies-mCherry identified numerous PVH neurons directly upstream of the 
OXTPVH neuronal population, with many rabies-mCherry cells in the PVH not co-labeling 
OXT peptide (Figure 4.6B).  Since the PVH is a heterogenous structure consisting of 
many different, largely nonoverlapping, neuropeptide populations, we aimed to test if 
some of the PVH inputs to OXTPVH neurons include vasopressin (AVP) neurons in the 
PVH (26).  Certainly, many rabies-mCherry neurons co-express OXT, indicating primary 
infected OXTPVH neurons (white arrows, Figure 4.6B-C).  In addition, some non-OXT 
rabies-mCherry neurons also express copeptin, the carrier molecule for AVP (yellow 
arrows, Figure 4.6B, C), suggesting direct AVPPVH innervation of OXTPVH neurons.  
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Although few rabies-mCherry neurons are identified outside of the PVH, the SON is the 
primary extra-PVH site with rabies-mCherry localization (Figure 4.6D).  The SON is 
comprised entirely of AVP and OXT neurons that are critical in regulating peripheral 
circulating levels of AVP and OXT via the posterior pituitary.  Rabies-mCherry 
localization appears to be in the vicinity of AVPSON neurons, though co-labeling is hard 
to identify due to copeptin localization primary in axons rather than cell bodies (Figure 
4.6E-G).  While few rabies-mCherry neurons are identified in OXTSON vicinity, at least 
one rabies-mCherry neuron co-labels OXT (Figure 4.6F).  This highlights the potential 
for AVPSON, and minimal OXTSON, innervation and regulation of OXTPVH neurons.   
To further characterize the intra-PVH circuitry engaging OXTPVH neurons, the 
same rabies virus procedure was performed in OXT-iCre +AAV-Flex-TVA-B19G mice in 
addition to PVH-directed treatment of colchicine 36 hours prior to perfusion in order to 
identify neurons expressing corticotropin-releasing factor (CRF).  CRF is rapidly 
trafficked to terminals, therefore requiring colchicine, a peptide transport inhibitor, for 
cell-body visualization (32).  Indeed, rabies-mCherry colocalizes with CRFPVH neurons 
(white arrows, Figure 4.6H).  Rabies-mCherry colocalization with OXTPVH neurons (blue) 
identifies primary infected neurons (yellow arrows), which are separate from CRFPVH 
neurons (green), indicating that some CRFPVH neurons are directly upstream of OXTPVH 
neurons.    
 OXTPVH projections to the NTS were previously thought to be a component of the 
ARC-PVH-NTS circuit, though recent studies suggest that OXT peptide expression in 
the NTS are fibers of passage (Chapter II)(19).  Still, we aimed to test this circuit using 
modified rabies virus techniques. OXT-iCre mice were crossed to a Cre-dependent 
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TdTomato reporter (OXT-iCre, Td) to visualize all OXTPVH cells and reduce the 
possibility of decreased OXT peptide expression as a result of rabies expression in 
cells.  OXT-iCre, Td mice were injected with helper virus in the PVH followed by rabies-
GFP injection in the NTS three weeks later (Figure 4.7A).  Certainly, some OXTPVH 
neurons co-express rabies-GFP, therefore identifying primary NTS inputs or fibers of 
passage (white arrows, Figure 4.7B, 7C).  Similar to results obtained with both helper 
and rabies viruses injected directly into the PVH, there are many non-OXT rabies-GFP 
PVH cells, likely identifying inputs to OXTPVH neurons with axonal projections in the 
NTS.  However, few rabies-GFP cells are identified outside of the PVH (Figure 4.7D-F).  
This is in stark contrast to the densely labeled CNS inputs to NTS-projecting Nos1PVH or 
Sim1PVH neurons, suggesting the capability for PVH circuit dissection using these 
approaches. 
 
Discussion 
Although significant advances have been made in the understanding of the 
PVH’s role in controlling energy balance, far less is understood about the afferent 
control of PVH populations projecting to hindbrain and spinal cord regions.  Certainly, 
the ARC-PVH circuit has been a primary area of research, since ARC POMC and AgRP 
neurons clearly control feeding primarily through the PVH (8, 9, 14, 30, 33).  Previously, 
it was hypothesized that the ARC-PVH-NTS circuit was the primary hypothalamic 
regulator of satiety (34).  However, recent advances using optogenetic techniques 
suggest that Mc4RPVH connections to the PBN control feeding suppression (9).  Yet, 
there is a large gap in the understanding of how distinct circuits engage different PVH 
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populations that are ultimately connected to the PBN, NTS, or IML.  Using recent 
advancements in genetic mouse models and neuroscience technologies, our studies 
begin to answer some of these questions and demonstrate the complexity of inputs to 
genetically-defined PVH circuits.  We demonstrate that PVH populations are highly 
interconnected, highlighting the potential for a large-scale PVH network in the regulation 
of different PVH projection sites. 
Until recently, reagents used for retrograde tracing were not dependent on Cre 
recombinase and therefore did not have the ability to map inputs to cell-type specific 
PVH populations.  More recently, modified rabies virus approaches have been 
generated to accomplish this task (21, 22).  Using a novel Cre-dependent helper virus 
capable of co-expressing both the rabies glycoprotein and TVA receptor in Cre-
expressing cells, we characterized inputs to Sim1PVH neurons.  We demonstrate that 
inputs to PVH neurons are largely similar to results obtained with other approaches, 
including the canonical POMCARC-PVH circuit (4, 30).  Next, we aimed to determine 
which sites specifically engage centrally-projecting parvocellular PVH circuits.  While 
results from dual rabies virus injection in the same mouse suggest distinct circuit 
regulation of NTS-projecting PVH populations in comparison to PBN-projecting PVH 
neurons, technical limitations surrounding rabies virus efficacy limit our ability to make 
definitive statements about these results.  Routinely, rabies-GFP injections in projection 
sites identified fewer GFP-labeled neurons than those expressing rabies-mCherry.  
Although rabies-mCherry and rabies-GFP can be co-expressed in the same neuron, it is 
possible that rabies-mCherry is more efficient than rabies-GFP.  Previous control 
studies indicate that while both rabies-GFP and rabies-mCherry can co-express in some 
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cells, the ability of cells upstream of the primary infection to express both viruses seems 
impaired (Chapter III).  Taken together, it is apparent that dual rabies virus approaches 
in the same mouse are limited in scope. 
Using a single rabies virus approach, monosynaptic inputs to projection-specific 
PVH populations were strikingly similar.  Moreover, despite different injection sites, it 
was apparent that rabies-mCherry routinely illuminated almost all PVH neurons.  
Therefore, it is likely that different Cre+ PVH populations were not only synapsing in 
distinct hindbrain sites, but also communicating with one another in a complex intra-
PVH network.  In this scenario, since helper virus expresses in all Cre+ neurons in the 
PVH, B19G is expressed in local PVH Cre+ neurons.  Therefore, rabies-mCherry labels 
CNS sites not only upstream of Cre+ neurons projecting to a distinct site but also all 
inputs to local, synaptically connected, Cre+ PVH neurons (Figure 4.4S).  Depending on 
the level of PVH interconnectivity, this technique could essentially mark all inputs to the 
PVH despite projection-defined rabies-mCherry injection.  Indeed, electrophysiologic 
data consistently suggests intra-PVH communication, since glutamatergic interneurons 
are sometimes required for changes in PVH electrical activity observed in response to a 
variety of receptor agonists (29, 35, 36).  Additionally, dendrodentric synapses have 
been identified between thyrotropin releasing hormone (TRH) producing neurons in the 
PVH, though the ability of modified rabies virus to travel retrogradely through 
dendrodentric synapses is unknown (37). 
Therefore, to both limit the primary Cre+ population infected with rabies-mCherry 
and further characterize PVH interconnectivity, we performed similar rabies-mCherry 
experiments in the OXTPVH population, a small subset of the Nos1PVH field.  Once again, 
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dense intra-PVH labeling was observed upstream of OXTPVH neurons, further 
supporting intra-PVH circuitry as the likely reason for similar extensive rabies-mCherry 
signaling in Nos1PVH and Sim1PVH rabies studies.  Additionally, identification of direct 
input from AVPPVH and CRHPVH neurons onto the OXTPVH population suggests a 
complex regulation of distinct PVH populations by adjacent neurons.  With this in mind, 
it is intriguing to consider the close proximity of dissimilar PVH populations in the control 
of a variety of physiologic functions not only related to energy balance but also including 
blood pressure control, stress responses, and reproduction.  The diverse nature of 
these functions are also highly interrelated; certainly these circuits should be connected 
at some level given the necessity of energy intake or sympathetic output for a variety of 
physiologic demands.  Whether the PVH mediates the coordination of such behaviors 
by multifaceted intra-PVH networks is a fascinating possibility that will require further 
investigation. 
OXTPVH neurons have long been implicated in the control of feeding behavior, 
presumably through an ARC-OXTPVH-NTS connection (34, 38).  However, numerous 
studies to date have questioned the ability for OXTPVH neurons to directly control 
feeding behavior (9, 15).  Our studies further prove that ARC populations are not 
synaptically connected to OXTPVH neurons, both through identifying inputs to the entire 
OXTPVH neuronal population as well as “NTS-projecting” OXTPVH neurons.  Since there 
are few, if any, OXTPVH terminals in the NTS, it is likely that rabies-GFP labeled OXTPVH 
neurons are marked by TVA-expressing fibers of passage headed through the NTS 
towards the spinal cord (Chapter II, Figure 2.4).  Taken together, it is clear that OXTPVH 
neurons primarily receive innervation from local PVH circuits and the SON, and not the 
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ARC or other hypothalamic structures.  Although the significance of this novel SON 
input to the PVH is unknown, the similar neuropeptide populations in the SON and PVH 
implicate this connection in the coordinated control of peptide release in the 
neurohypophysis and corresponding endocrine regulation.  Previous results also 
indicate that the SON is upstream of other non-OXT PVH populations (e.g. IRS4), 
therefore suggesting the possibility for SON regulation of parvocellular PVH function in 
the control of energy balance parameters, though this remains to be determined 
(Chapter III).   
Overall, here we provide a novel anatomical framework for understanding the 
regulation of PVH subsets by sites throughout the hypothalamus, forebrain, and 
brainstem.  It is clear that dense interconnectivity occurs at the level of the PVH, and 
that these intra-PVH networks have the potential to regulate PVH outputs at diverse 
brainstem and spinal cord projection targets.  As the primary hypothalamic output, the 
PVH is well situated to coordinate a multitude of different responses in order to achieve 
homeostasis.  While these studies highlight the potential ability of this node to respond 
and function as an organized structure, further studies are needed to test the 
significance of this interaction.  Furthermore, while the regulation of the smaller OXTPVH 
population was identified using these techniques, troubleshooting with modified rabies 
virus approaches will need to be performed in future experiments to address 
interconnected PVH networks, potentially through identifying smaller genetic PVH 
populations with limited overlap.  Ultimately, these approaches have the potential to 
identify novel circuits capable of regulating discrete energy balance parameters through 
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disparate projection targets, thereby providing useful targets for obesity and its 
comorbidities. 
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Figure 4.1. Modified rabies virus allows for identification of monosynaptic inputs 
to Cre-expressing PVH populations.  A) Using a 2A linker, a helper virus was 
generated to express the TVA receptor and B19 glycoprotein (B19G/rabiesG) in Cre-
expressing cells.  B) Modified rabies virus expresses mCherry instead of the 
endogenous B19G, therefore requiring prior injection of AAV-Flex-TVA-B19G.  C-D) 
Immunohistochemistry (IHC) identifies dense rabies-mCherry expression throughout the 
PVH of Sim1-Cre +AAV-Flex-TVA-B19G mice injected with rabies-mCherry in the PVH.  
Rabies-mCherry expression in the SON identifies SON projections to Sim1PVH neurons.  
E-J) Sites identified upstream of the PVH include the bed nucleus of the stria terminalis 
(BNST, E-F), preoptic area (POA, E-F), arcuate nucleus (ARC, G-J), ventromedial 
hypothalamus (VMH, G-H), and lateral hypothalamic area (LHA, G-I).  K-N) IHC was 
performed for ACTH and rabies-mCherry demonstrating POMCARC regulation of the 
PVH using this approach.  3V=third ventricle, aca=anterior part of anterior commissure, 
MePO=median preoptic area, MPOA=medial preoptic area, DMH=dorsomedial 
hypothalamus, oc=optic chiasm. 
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Figure 4.2. Terminal-specific modified rabies virus injection identifies PVH 
populations regulating PBN and NTS outputs.  A) Sim1-Cre +AAV-Flex-TVA-B19G 
and Nos1-iCre +AAV-Flex-TVA-B19G mice were injected with rabies-GFP in the PBN 
and rabies-mCherry in the NTS to determine if PVH neurons collateralize to different 
projection sites.  B-D) IHC throughout the PVH demonstrates little overlap between 
rabies-mCherry, identifying NTS-projecting Sim1PVH neurons, and rabies-GFP, labeling 
PBN-projecting Sim1PVH neurons.  E-G) Similar distribution of rabies-mCherry and 
rabies-GFP is observed in the PVH of Nos1-iCre +AAV-Flex-TVA-B19G mice.  Dashed 
boxes indicate regions that are digitally enlarged and shown as insets.  3V=third 
ventricle 													
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Figure 4.3 Inputs to NTS-projecting or PBN-projecting PVH populations are 
distinct.  A)  Monosynaptic inputs to PBN-projecting Sim1PVH and Nos1PVH populations 
are identified with rabies-GFP, whereas sites upstream of NTS-projecting Sim1PVH and 
Nos1PVH neurons are labeled by rabies-mCherry. B-H) IHC for GFP and mCherry 
identifies little overlap in neuronal populations upstream of Sim1PVH populations 
projecting to the PBN or NTS, respectively. J, L) Rabies-GFP (J) and rabies-mCherry 
(L) injection sites are identified by glial damage.  C-I) Similar localization of rabies-
mCherry and rabies-GFP is demonstrated by neurons upstream of the smaller Nos1PVH 
population when rabies-GFP was injected in the PBN (K) and rabies-mCherry into the 
NTS (M). fx=fornix, aq=aqueduct, scp=superior cerebellar peduncle, cc=central canal, 
DMV=dorsal motor nucleus of the vagus, AP=area postrema, ZI=zona incerta 
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Figure 4.4. Projection-specific rabies-mCherry injection reveals similar inputs to 
Sim1PVH neurons projecting to the NTS, PBN, or IML.  A-C) Sim1-Cre +AAV-Flex-
TVA-B19G mice were injected with rabies-mCherry in the NTS (A), PBN (B), or IML (C) 
to compare inputs to projection-defined Sim1PVH neurons.  D-F) Similar localization of 
rabies-mCherry is observed in BNST and POA neurons upstream of NTS-projecting (D), 
PBN-projecting (E), or IML-projecting (F) Sim1PVH neurons.  G-I) Despite different 
rabies-mCherry injection sites, dense rabies-mCherry expression is observed 
throughout the PVH.  J-L) ARC, VMH, DMH, and LHA populations are all upstream of 
Sim1PVH neurons projecting to different sites. M, O) PBN neurons lie upstream of NTS-
projecting (M) and IML-projecting (O) Sim1PVH neurons.  N, P) Gliosis identifies rabies-
mCherry injection site in experiments testing inputs to PBN-projecting (N) or NTS-
projecting (P) Sim1PVH neurons (N).  Q-R) Few NTS neurons lie upstream of 
parvocellular Sim1PVH neurons. S) Diagram depicting possible caveat with projection-
specific modified rabies virus approaches.  Since B19G is expressed in all Sim1-Cre+ 
neurons in the PVH, including neurons not projecting to the rabies-mCherry injection 
site, intra-PVH connectivity allows for multi-synaptic retrograde transmission of rabies-
mCherry. 
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Figure 4.5. Inputs to projection-defined Nos1PVH neurons reveal intra-PVH 
network.  A-C) Rabies-mCherry injection was performed in distinct projection sites of 
Nos1PVH neurons, a subset of the Sim1PVH neuronal field, in Nos1-iCre +AAV-Flex-TVA-
B19G mice.  Forebrain (D-F) and hypothalamic (J-L) inputs to NTS-projecting, PBN-
projecting, or IML-projecting Nos1PVH neurons are similar to those observed from the 
entire PVH (using Sim1-Cre, Figure 4.4).  G-I) Rabies-mCherry identifies dense labeling 
in the PVH despite different rabies-mCherry injection sites. M,O) PBN neurons are 
upstream of NTS-projecting Nos1PVH neurons (M), whereas rabies-mCherry expression 
is largely absent in the PBN of mice with IML-directed rabies-mCherry injections (O).  N, 
P) Glial damage identifies rabies-mCherry injection sites in the PBN (N) and NTS (P).  
Q-R) Few NTS neurons are upstream of Nos1PVH neurons projecting to the PBN or IML.       
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Figure 4.6. Intra-PVH circuits are upstream of OXTPVH neurons.  A) Monosynaptic 
inputs to OXTPVH neurons, a small subset of the Nos1PVH neuronal population, are 
identified using PVH-directed injection of rabies-mCherry in OXT-iCre +AAV-Flex-TVA-
B19G mice.  B-C) Rabies-mCherry labeling demonstrates that monosynaptic inputs to 
OXTPVH neurons (green, white arrows) are largely from non-OXTPVH populations, 
including those expressing copeptin, the carrier molecule for AVP (blue, yellow arrows).  
D).  Although few non-PVH sites lie upstream of OXTPVH neurons, expression of rabies-
mCherry is obxserved in the SON.  E-G) Rabies-mCherry identifies SON inputs to 
OXTPVH neurons largely in the vicinity of AVPSON neurons (blue).  H) PVH-directed 
colchichine in OXT-iCre +AAV-Flex-TVA-B19G mice with rabies-mCherry injection in 
the PVH allows for detection of CRFPVH neurons (green) that co-express rabies-
mCherry (white arrows), demonstrating CRFPVH regulation of OXTPVH neurons (identified 
by neurophysin, blue).  Co-localization of neurophysin and mCherry identifies primary 
infected OXTPVH neurons (yellow arrows). Dashed boxes indicate regions that are 
digitally enlarged and shown as insets.  3V=third ventricle, SON=supraoptic nucleus, 
CRF=cortiocotropin releasing factor, OXT=oxytocin, AVP=vasopressin 
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Figure 4.7. Intra-PVH regulation of OXTPVH neuronal populations projecting 
through the NTS.  A) Rabies-GFP was injected in the NTS of OXT-iCre,Td +AAV-Flex-
TVA-B19G mice to determine inputs to OXTPVH neurons connected to the NTS, likely 
via OXTPVH fibers of passage.  B-C) Co-localization of OXT-iCre, Td neurons (red) with 
rabies-GFP (green) identifies NTS-projecting OXTPVH neurons (white arrows).   D-F) 
Limited rabies-GFP expression is observed outside of the PVH, demonstrating that 
inputs to OXTPVH neurons projecting through the NTS are regulated by sites within the 
PVH.  Dashed boxes indicate regions that are digitally enlarged and shown as insets.   
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Chapter V 
Discussion: Distinct PVH subpopulations control energy balance in an intra-PVH 
network 
 Early lesioning studies that destroyed the cellular components of the PVH 
demonstrated a critical role for this complex nucleus in restraining food intake (1, 2).  
Since PVH neurons are heterogeneous and largely distinct, interrogation of the entire 
PVH, such as what occurs with anatomical lesions, does not discriminate the 
capabilities of different PVH circuits to regulate disparate functions, including feeding 
behavior and energy expenditure.  Studies to date have interrogated both the 
neurocircuitry and function of the neuropeptidergic PVH neurons through the use of 
nonspecific tracing reagents in combination with knock-out rodent models in an attempt 
to link potential function with PVH projection targets (3-6).  These studies suggested 
that known neuropeptide populations encompass just 25% of the PVH neurons 
projecting to hindbrain or spinal cord regions, highlighting a significant gap in our 
knowledge of the neurochemical identity of PVH circuits regulating autonomic function 
(7).  
Significant questions remain regarding the ability of PVH neurons to control 
energy balance parameters: does a single PVH population regulate feeding 
suppression, or can this be achieved by multiple, redundant PVH neuronal 
subpopulations? Do PVH neurons increase energy expenditure, and if so, which 
neurons coordinate this response?  What are the afferent circuits engaging PVH
163
 subpopulations?  Which circuits are used by PVH neurons to carry out diverse 
physiologic responses, and are these circuits mutually exclusive?  In this dissertation, I 
have addressed some of these questions with the use of novel genetic mouse models in 
combination with viral reagents to clarify the circuitry and function of PVH cell-types in 
energy balance control.   
 
Multiple PVH populations can control feeding suppression and energy 
expenditure 
With these studies, we characterize different genetically-marked PVH subpopulations 
that are largely independent of one another (with the exception of OXTPVH neurons).  
Our initial experiments suggested that a non-OXT Nos1PVH neuronal population was the 
primary PVH controller of feeding behavior.  Additional studies demonstrate that 
IRS4PVH neurons, an independent population that does not express Nos1 or OXT, are 
also sufficient for feeding and energy expenditure regulation.  This demonstrates the 
capacity of multiple, separate PVH populations to control both these parameters and 
suggests that PVH populations may act redundantly in energy balance regulation.  
Moreover these distinct neuronal subsets also send dense projections to the same 
hindbrain and spinal regions, providing a potential mechanism for PVH neuronal 
subpopulations to each control feeding and energy expenditure parameters, 
respectively.  These initial studies testing sufficiency demonstrated that Nos1 and IRS4 
are novel markers of independent PVH populations capable of achieving similar 
physiologic effects in terms of energy balance regulation.   
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As the primary pre-autonomic hypothalamic output, it would make sense for PVH 
circuits to be redundant in nature (8, 9).  Coordinating a robust sympathetic response is 
necessary in a variety of physiologic responses, and suppression of feeding must be 
achieved at some point during meal ingestion due to the immediate physical limitations 
of energy intake.  With the increasing prevalence of substantial energy intake and 
corresponding diseases such as obesity, these, potentially redundant, circuits would 
provide multiple avenues for therapeutic intervention.  Future studies employing cell-
specific RNA analysis in these different PVH subpopulations could identify the 
molecular identity of IRS4PVH and Nos1PVH neurons and therefore exploit multiple 
pathways for intervention.  
While our initial chemogenetic activation studies suggest redundancy in the 
capability of PVH populations to control energy balance parameters, other studies 
testing the necessity of IRS4PVH neurons in feeding regulation call this theory into 
question.  Indeed, neuronal silencing or ablation of IRS4PVH neurons, a population 
separate from Nos1PVH neurons, results in robust obesity due to hyperphagia.   
Therefore, this suggests that while activation of Nos1PVH neurons is sufficient to drive 
changes in feeding behavior, perhaps this response is dependent on intra-PVH 
networks requiring IRS4PVH neuronal activity.  This theory is further supported by the 
fact that OXTPVH neurons, a subset of the Nos1PVH population, are not necessary for 
feeding behavior.  Indeed, we demonstrate dense interconnected PVH neurons 
upstream of hindbrain-projecting IRS4PVH or Nos1PVH neurons.  Certainly, depending on 
the level of PVH interconnectivity, chemogenetic approaches used throughout these 
studies to activate specific PVH subsets could essentially activate large PVH 
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populations that are not limited to the subset in question.  Whether these interconnected 
populations are required for the feeding effects observed upon chemogenetic activation 
is unknown.   
Despite the sufficiency of IRS4PVH neurons to drive increased energy 
expenditure, silencing or ablation of these neurons demonstrates that the IRS4PVH 
population is not necessary for normal energy expenditure. These results highlight the 
potential for PVH subsets to be sufficient, but not necessary, in individual energy 
balance parameters.  Moreover, these results suggest that other PVH populations are 
the relevant regulators of energy expenditure, in the absence of redundancy.  Though 
undetermined in these studies, if Nos1PVH neurons are necessary for energy 
expenditure regulation, it would suggest that PVH energy expenditure circuits are not 
redundant, and that Nos1PVH neurons are the necessary output in energy expenditure 
regulation.  To this point, previous reports testing the necessity of OXT and/or OXTPVH 
neurons, a Nos1PVH subset, suggest the importance of sympathetic output by these 
neurons in the prevention of diet-induced obesity.  Similarly, in the context that Nos1PVH 
neurons are sufficient, but not necessary for feeding regulation, this would demonstrate 
a lack of redundancy in PVH circuits controlling feeding, since IRS4PVH neurons are 
clearly necessary in feeding regulation.  With this model, PVH circuits would not be 
redundant, since the Nos1PVH population would control energy expenditure and IRS4PVH 
neurons would mediate feeding suppression (Figure 5.1).  Yet, due to intra-PVH 
networks, these neuronal populations could change both energy balance parameters, 
likely via activation of one another.  Future experiments ablating or silencing Nos1PVH 
neurons would aid in determining the necessity of Nos1PVH neurons in comparison to 
166
the IRS4PVH population, and further our understanding of the potential connections 
between these populations in the regulation of physiologic outputs.  Since current 
technology limits our ability to detect small decreases in energy expenditure, future 
studies investigating the necessity of these populations in energy expenditure regulation 
would benefit by determining if PVH subset silencing affects cold-induced increases in 
sympathetic output.  
Our studies show that multiple PVH neuronal populations are capable of 
controlling distinct energy balance parameters.  This raises the possibility that the PVH 
populations studied may share some degree of overlap.  In Nos1PVH studies, a Cre-
dependent reporter mouse was used in combination with immunohistochemical 
identification of different PVH subtypes.  Therefore, PVH subtype analysis may be 
confounded somewhat by developmental expression of Cre activity by PVH cell types.  
Certainly, Nos1 immunoreactivity (IR) in adult mice labels far fewer neurons than those 
identified by Cre-dependent reporter mice.  It is unknown if this discrepancy is due to 
limited Nos1 antibody efficacy.  Therefore, since we determined that OXTPVH neurons 
are a Nos1PVH neuronal subset using reporter mice, it is possible that these populations 
show limited overlap in the adult mouse.  However, studies using antibodies for both 
OXT peptide and Nos1 peptide in the same brain suggest this is unlikely.  The 
characterization of Nos1PVH versus IRS4PVH neuronal populations is more difficult, since 
antibodies for IRS4 peptide are unavailable, and germline recombination of reporter 
constructs crossed to IRS4-iCre mice limits the use of reporter mice to identify IRS4PVH 
neurons.  Since our studies used PVH-directed viral reagents dependent on the active 
expression of Cre recombinase in adult mice, characterization of Cre-expressing PVH 
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neurons is likely best achieved via injection of a Cre-dependent reporter virus in the 
PVH of IRS4-iCre or Nos1-iCre mice.  While IRS4PVH neurons identified with this 
approach demonstrate distinct IRS4PVH and Nos1PVH neuronal populations, future 
studies employing in situ hybridization could also be used to validate the extent of 
overlap. 
 
PVH circuit mechanisms underlying energy balance control 
While these studies identify the projection targets that the PVH may engage to alter 
feeding and energy expenditure, the specific circuitry used by PVH subpopulations to 
control different physiologic outcomes has not been determined.  It is likely that 
projections to thoracic spinal cord regions that regulate sympathetic output (i.e. IML) 
represent the main PVH output driving increased energy expenditure (7, 10, 11).  
Conversely, direct connections to hindbrain regions capable of sensing gastrointestinal-
derived mechanical and peripheral energy status signals are probably coordinating the 
PVH-mediated satiety response (12, 13).  Yet, which hindbrain site mediates this effect 
is unknown.  Theories of PVH projections to the NTS as the primary circuit coordinating 
melanocortin-induced satiety were recently brought into question, since Mc4RPVH 
neuronal projections to the PBN, but not the NTS, appear to be the relevant PVH circuit 
controlling feeding suppression (14).  However, the optogenetic approaches used to 
decipher the functional relevance of these circuits should be interrogated, since 
terminal-specific activation of PVH projection targets does not eliminate the possibility of 
action potential back-propagation (15). In addition, we have shown that PVH 
populations projecting throughout the CNS are highly interconnected.  It is therefore 
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possible that optogenetic activation of Mc4RPVH terminals in one projection site (i.e. 
PBN) could result in the unintended activation of other local PVH neurons with wider 
projection targets (i.e. NTS, IML).  Future studies could employ terminal-specific 
inhibitory optogenetic approaches, thereby eliminating the possibility of action potential 
back-propagation and the potential large-scale PVH neuronal activation following 
activation of one PVH subset.  These studies would therefore clarify the role of specific 
PVH subset projection targets in controlling feeding behavior and energy expenditure. 
 Future studies will be required to determine the mechanism used by IRS4PVH and 
Nos1PVH neurons to regulate feeding suppression.  Melanocortinergic input to the PVH, 
a primary site of Mc4R expression, is widely considered to be the likely mechanism of 
PVH-controlled satiety regulation (6, 16, 17).  Certainly, Mc4RPVH neuronal function is 
necessary for normal feeding control (6, 18).  Yet, Mc4RPVH neurons are a relatively 
small proportion of the entire PVH, and have little overlap with neuropeptidergic PVH 
neuronal populations hypothesized to control feeding behavior (18).  Though unstudied 
in this dissertation, it is possible that the Nos1PVH and IRS4PVH populations contain 
Mc4R, and therefore are a component of the Mc4R-mediated satiety response.  Due to 
the lack of antibodies specific to Mc4R or IRS4 peptides, the overlap between these 
populations is unknown.  Nos1PVH and IRS4PVH populations likely contain non-Mc4R 
neurons, since chemogenetic activation of these populations alters energy expenditure 
whereas activation of the Mc4RPVH neuronal population does not.  While previous 
approaches used genetic mouse models to eliminate or re-express Mc4R on 
genetically-identified PVH populations, this approach would have limited application for 
IRS4PVH or Nos1PVH neurons since extra-PVH expression of IRS4, Nos1, and Mc4R is 
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broad, therefore making it difficult to limit studies to the PVH.  Future experiments using 
more specific CRISPR/Cas9 reagents could abrogate these problems in order to 
determine the necessity of Mc4R on IRS4PVH or Nos1PVH neurons. 
   
OXTPVH neuronal circuits do not control feeding behavior 
Substantial research indicates that OXTPVH neurons project to the NTS and coordinate a 
satiety response (4, 5, 19).  Moreover an increasing number of therapeutic approaches 
are using OXT administration in humans to suppress feeding and therefore treat obesity 
(20).  OXTPVH neurons were initially highlighted as a viable candidate for PVH-mediated 
feeding suppression, since obese Sim1 haploinsufficient mice routinely demonstrated 
disproportionate decreases in Oxt expression (21, 22).  Moreover, central administration 
of OXT in rodents can suppress feeding (23, 24).  Recent studies highlighted the 
necessity of OXT neuronal inhibition to achieve AgRP-induced feeding suppression 
using viral reagents driving transgene expression from a relatively short OXT promoter 
element (19).   
The evidence for OXTPVH neuronal projections to hindbrain structures came from 
co-labeling of NTS-injected retrograde tracing reagents with OXT-IR in the PVH (4, 5, 
7).  However, the ability of these retrograde tracing reagents to infect fibers of passage 
has been documented, suggesting the possibility that these connections are potentially 
fibers of passage headed to the spinal cord (25, 26).  Indeed, using a novel OXT-iCre 
mouse model, we demonstrate dense OXTPVH innervation of the IML, and few synaptic 
terminals in the NTS arising from OXTPVH neurons.  In addition, NTS-directed injection 
of latex microspheres which are transported in a retrograde fashion fail to label OXT-IR 
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in the PVH.  Moreover, our studies clearly demonstrate that OXTPVH neuronal activation 
cannot alter feeding behavior.  Recently, studies employing the same OXT-iCre mice 
used in our studies validated that OXTPVH neurons are not synaptically connected to 
AgRP neurons, and that OXTPVH neuronal inhibition is not required for AgRP-induced 
feeding (14).  Our rabies virus results support these findings, since ARC populations are 
not monosynaptically connected to OXTPVH neurons.  These studies highlight the 
importance of using the OXT-iCre mouse model rather than the previously used viral 
approaches that are likely less specific to the OXTPVH neuronal population.   
Our results demonstrate the inability of OXTPVH neuronal activation to change 
feeding behavior; this is in contrast to previous studies that demonstrate feeding 
suppression following pharmacologic administration of OXT in rodents and humans (20, 
23, 24). Anorexic responses to high dose oxytocin administration could possibly be due 
to off-target pharmacologic effects or engagement of OXTR in peripheral sites.  
However, since we were unable to dissociate between central and pituitary-projecting 
OXTPVH neurons, our chemogenetic activation studies may have also increased 
circulating OXT; this was still unable to change feeding behavior.  It is important to note 
that OXT production is not limited to the PVH and that OXTSON neurons are the primary 
source of circulating OXT.  While this suggests the unlikely potential for non-PVH OXT 
to coordinate peripheral OXTR-mediated anorexia, additional experiments employing 
chemogenetic or optogenetic activation of OXTSON neurons would be required to test 
this hypothesis.  
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Intra-PVH networks  
Using a combination of modified rabies virus approaches, we demonstrate that PVH 
subpopulations are highly interconnected, and that this network has the potential to 
regulate multiple sites downstream of the PVH.  Consistently, we demonstrate that 
rabies virus tracing identifies dense local PVH inputs to NTS-projecting, IML-projecting 
or PBN-projecting PVH neurons.  While these studies do not test the functional 
implications of this interconnected network, it is plausible that multiple neuronal 
subpopulations within the PVH (e.g. Nos1, IRS4, OXT) all communicate different 
information relevant to energy balance in order to achieve a coordinated physiologic 
response.  Although the separate IRS4PVH and Nos1PVH neuronal populations have 
similar functions and projection targets, the presence of an intra-PVH network further 
suggests the possibility that these pathways are not redundant but instead are 
coordinated in a complex local circuit to ultimately drive a functional output.  Studies 
testing the necessity of IRS4PVH neuronal activity demonstrate this, since IRS4PVH 
neurons are required for the feeding response, even though Nos1PVH neurons, a 
population capable of decreasing feeding, should be unaffected in this situation.  Future 
studies exploring the electrophysiology of non-IRS4PVH neurons following IRS4PVH 
neuronal ablation or silencing would provide valuable information regarding the 
importance of interconnected PVH circuits in coordinating energy balance. 
The relevance of dense connectivity between the highly heterogenous PVH 
populations, likely both magnocellular and parvocellular, in the regulation of circuits 
projecting to hindbrain and spinal cord sites makes sense in the overall regulation of 
energy balance.  PVH neurons are not only important in the regulation of feeding and 
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energy expenditure but are also essential in the control of a variety of physiologic and 
behavioral responses, including reproduction, stress responses, anxiety-related 
behaviors, blood pressure control, and growth (27-29).  Certainly, these diverse 
physiologic functions are highly interrelated and should be communicating to coordinate 
appropriate homeostatic responses.  While previous studies demonstrated that PVH 
populations had the capability of communicating with one another, they did not 
demonstrate that these PVH circuits were ultimately connected to hindbrain and spinal 
cord structures (30, 31).   Thus, these studies greatly advance our understanding of the 
circuit mechanisms potentially used by the PVH to control complex physiologic 
outcomes.  Moreover, this positions the PVH, a primary controller of feeding behavior, 
as a potential integrator of a variety of circuits and signals that coordinates appropriate 
feeding responses depending on the current physiologic state.  More specifically, these 
intra-PVH networks have the potential to mediate a variety of physiologic paradigms 
that result in dysregulated energy balance such as anorexia, stress-induced feeding, 
dehydration-induced anorexia, and bulimia, to name a few.  Therefore, further 
interrogation of the relevance of these interconnected circuits in a variety of behavioral 
paradigms associated with energy balance would greatly advance our understanding of 
PVH-controlled feeding behavior and energy expenditure.     
Given the dense interconnectivity among PVH populations, it is tempting to 
consider the endogenous neuronal activity patterns of PVH subpopulations, especially 
as it relates to energy balance control.  While PVH populations clearly communicate 
with one another, such as the demonstrated AVPPVH neuronal innervation of OXTPVH 
neurons, we did not determine the neuronal physiology of these connections.  Since 
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PVH neuronal populations are predominately glutamatergic, it is tempting to 
hypothesize that neuronal activation of AVPPVH neurons would increase the activity of 
OXTPVH neurons.  From a broader perspective, activation of one PVH subtype could 
therefore result in large-scale neuronal activity of the entire PVH.  It is also possible that 
glutamate in PVH neurons could bind metabotropic glutamate receptors (mGluR) to 
achieve pre-synaptic inhibition.  Though relatively unstudied, this would provide intra-
PVH networks the ability to either activate or inhibit distinct circuits in order to carry out 
complex physiologic parameters.  In addition to glutamate, intra-PVH connections likely 
use neuropeptides to communicate, though changes in neuronal activity resulting from 
neuropeptide release would be on a slower time scale than fast-acting 
neurotransmitters.  Future studies employing ex vivo and/or in vivo calcium imaging 
techniques could test these hypotheses and further our understanding of the underlying 
activity patterns used by interconnected PVH networks to potentially regulate energy 
balance.  
 Our initial goal with the modified rabies virus tracing system was to determine if 
PVH circuits engaging distinct hindbrain sites (i.e. PBN vs. NTS) overlapped.  
Unfortunately, we found that rabies-GFP viral efficacy was lower than rabies-mCherry, 
limiting our ability to make definitive conclusions about the extent of overlap between 
the populations upstream of NTS-projecting or PBN-projecting PVH neurons.  
Moreover, we were unable to determine if PVH neurons collateralize to distinct 
projection targets, since rabies-GFP and rabies-mCherry labeling identified not only 
primary PVH neurons projecting to the PBN or NTS, but also the intra-PVH network 
upstream of these PVH neurons.  Previous reports have employed a TVA-only helper 
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virus in order to determine if PVH populations collateralize to more than one projection 
site, since terminal-specific injection of modified rabies virus allows for visualization of 
primary PVH neurons and their projection targets (14, 32).  For example, the lack of 
rabies-labeled terminals in the NTS of mice in which rabies tracing was performed in 
PBN-projecting Mc4RPVH neurons suggests that Mc4RPVH neurons do not send 
collateral projections to both the PBN and NTS (14).  Yet, the reagents used in these 
studies employed a TVA-only helper virus that also expresses mCherry for visualization 
of injection site, limiting its use to rabies-GFP variants only.  Given that our results 
suggest lower efficacy of the rabies-GFP virus, this approach likely underestimates 
Mc4RPVH populations projecting the PBN and their axons.  To ameliorate this problem, 
future studies will employ a novel Cre-dependent TVA-HA helper virus that allows the 
use of rabies-mCherry in addition to labeling the injection site by HA-IR.  With this 
approach, we will determine if PVH subpopulations collateralize to multiple projection 
sites, as well as further characterize the primary PVH neuronal subpopulations 
projecting to distinct sites. 
Our results clearly demonstrate that numerous hypothalamic and forebrain sites 
densely innervate PVH subpopulations.  However, the presence of a highly 
interconnected PVH network hinders our ability to generate discrete circuit maps of the 
afferent inputs engaging projection-specific PVH subpopulations.  Specifically, we 
determined that intra-PVH connections between Cre+ populations likely resulted in 
multi-synaptic retrograde transmission of modified rabies virus.  Therefore, while we 
attempted to specifically label inputs to PBN-projecting, NTS-projecting, or IML-
projecting PVH neurons, these results largely reflected rabies virus tracing from all Cre+ 
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neurons in the PVH (Chapter IV, Figure 4.4S).  Although this reflects a significant 
limitation of the projection-specific rabies virus approach, it also emphasizes the degree 
of interconnectivity between PVH populations that are ultimately upstream of distinct 
hindbrain or spinal cord sites.  Future studies attempting to identify monosynaptic inputs 
to projection-defined PVH subpopulations would benefit from interrogating smaller PVH 
subsets and prior clarification of limited connectivity between Cre-expressing 
populations.  
Overall, our studies demonstrate the importance of interrogating genetically-
defined PVH circuits in the characterization of the PVH’s ability to control energy 
balance.  While multiple PVH subpopulations are capable of controlling feeding and 
energy expenditure, we highlight the potential for intra-PVH networks to regulate these 
distinct parvocellular PVH populations projecting throughout the brain.  The significance 
of this interconnectivity cannot be understated, since heterogenous PVH neuronal 
populations regulate a variety of physiologic responses.  The potential for a circuit 
connection between these responses in a single anatomical site such as the PVH could 
provide an inroad to understanding complex behaviors associated with energy balance 
control.  Furthermore, the characterization of genetic populations within this complex 
PVH network has the potential for identification of therapeutic markers and/or 
approaches to a variety of complex diseases associated with dysregulated energy 
balance.  Our discoveries highlight the complexity of examining the cellular biology of 
heterogenous nuclei such as the PVH.  Emerging technological approaches including in 
vivo calcium imaging, optogenetics, and terminal-specific chemogenetic reagents will 
greatly enhance our ability to understand the endogenous network activity and 
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relevance of PVH circuits used to coordinate the homeostatic regulation of energy 
balance.  Additionally, the development of intersectional genetic tools with multiple 
recombinases (Cre, Flp, Dre) will allow for finer scale dissection of complex nuclei such 
as the PVH.  After all, much like the proportion of previously characterized centrally-
projecting PVH populations discovered by Sawchenko et. al., our current understanding 
of PVH circuits is likely less than 25% of all the mechanisms used by this nucleus to 
coordinate the complex regulation of energy balance.    
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Figure 5.1. Distinct neurocircuits in an intra-PVH network regulate feeding 
and energy expenditure. A) Model of hypothesized interactions between 
independent PVH populations demonstrates the potential interconnectivity 
between Nos1PVH, IRS4PVH, Mc4RPVH, and endocrine PVH neurons (yellow). B) 
Model for potential circuit mechanisms employed by PVH subpopulations in the 
regulation of satiety, energy expenditure, and endocrine output. Since Mc4RPVH 
projections to the PBN have been implicated in the control of feeding 
suppression, it is likely that Nos1PVH and/or IRS4PVH projections to this site 
mediate the satiety response.  The function of Nos1PVH, IRS4PVH, and Mc4RPVH 
neuronal projections to the NTS are unknown, but might mediate energy 
expenditure and/or feeding suppression.  On the other hand, PVH projections to 
the IML originate from OXTPVH, Nos1PVH and IRS4PVH neurons, and likely 
coordinate sympathetic output and corresponding energy expenditure regulation.  
Neuroendocrine PVH neurons (including CRH, OXT, and AVP) regulate pituitary 
function via direct projections pituitary projections or the hypophyseal portal 
system.    
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